Electrochemical Sensors for Real-Time Veterinary Pathogen Monitoring

Overview and Principles of Electrochemical Sensors for Real-Time Veterinary Pathogen Monitoring

The escalating global demands for food security, coupled with the intensification of livestock and aquaculture production systems, have created an urgent imperative for diagnostic platforms capable of delivering real-time, on-site pathogen surveillance. Traditional diagnostic paradigms-microbiological culture, polymerase chain reaction (PCR), and enzyme-linked immunosorbent assay (ELISA)-while foundational, are fundamentally constrained by protracted turnaround times, reliance on centralized laboratory infrastructure, and the requirement for highly trained personnel [31, 32, 39]. These limitations are particularly acute in veterinary settings, where the rapid spread of highly contagious pathogens across herd or flock populations demands intervention windows measured in hours, not days. The emergence of electrochemical sensors represents a transformative shift in veterinary clinical pathology, offering the promise of continuous, quantitative, and minimally invasive monitoring directly at the point of care, whether in a barn, feedlot, aquaculture facility, or wildlife rehabilitation center [31, 39]. This section establishes the foundational principles governing these sensors, delineating the physicochemical mechanisms of signal transduction, the critical roles of biorecognition elements and nanomaterials, and the specific biological contexts that render electrochemical platforms uniquely suited for real-time veterinary pathogen detection.

Foundational Principles of Electrochemical Signal Transduction

At its core, an electrochemical sensor functions as a transducer that converts a biological recognition event-be it a pathogen-antibody interaction, nucleic acid hybridization, or enzymatic turnover-into a quantifiable electrical signal [31, 32, 36]. The fundamental architecture comprises a working electrode (often modified with functional materials and biorecognition elements), a reference electrode, and a counter electrode, all of which are integrated into a circuit where the measured current, potential, or impedance is directly proportional to the concentration of the target analyte. The choice of electrochemical technique dictates the nature of the information obtained. Amperometric sensors operate by measuring the current generated at a fixed potential during the oxidation or reduction of an electroactive species, making them ideal for monitoring metabolites like hydrogen peroxide or enzymatically-generated products [23, 36]. Potentiometric sensors measure the accumulation of charge potential at the working electrode under conditions of zero current, typically using ion-selective electrodes to detect pH changes or ionic byproducts of microbial metabolism [28]. However, for pathogen detection, electrochemical impedance spectroscopy (EIS) and voltammetric methods (including cyclic voltammetry (CV) and differential pulse voltammetry (DPV)) have emerged as particularly powerful modalities.

EIS probes the interfacial properties of the electrode by applying a small-amplitude sinusoidal potential over a range of frequencies and measuring the resulting impedance. This technique is exquisitely sensitive to changes in the electrode surface, such as those caused by the binding of bacterial cells to immobilized antibodies or aptamers, which alter the charge transfer resistance (Rct) and the double-layer capacitance [16, 18]. For instance, the real-time monitoring of biofilm formation by Pseudomonas aeruginosa on microfabricated interdigitated electrodes has been demonstrated in complex media, with the constant phase element (CPE) magnitude tracking the progressive accumulation of biomass over days [35]. Similarly, label-free EIS-based aptasensors have achieved detection limits as low as 30 CFU/mL for Campylobacter jejuni by monitoring the impedance increase following specific capture of the pathogen onto a gold nanoparticle-MXene-modified electrode [11]. Voltammetric techniques, by contrast, provide a dynamic electrochemical fingerprint of redox-active species. Differential pulse voltammetry (DPV) and square wave voltammetry (SWV) are particularly advantageous because they discriminate against capacitive background currents, yielding sharp, well-resolved peaks for electroactive analytes. This capability is directly exploitable for detecting pathogens that secrete redox-active virulence factors, such as the phenazine pyocyanin produced by P. aeruginosa [12, 13, 20, 26]. The ability to monitor the real-time production of these metabolites provides an indirect but highly specific window into bacterial metabolic activity and virulence state, a concept central to modern electrochemical biosensing.

Signal Generation: The Interplay of Biorecognition and Nanomaterial Amplification

The sensitivity and specificity of an electrochemical sensor are fundamentally governed by its biorecognition layer. The selection of the biological receptor-whether an antibody, nucleic acid aptamer, peptide, or molecularly imprinted polymer-must be optimized for target affinity, stability under field conditions, and compatibility with the chosen transduction modality. Antibody-based immunosensors leverage the high specificity of polyclonal or monoclonal antibodies, often immobilizing them on the electrode via self-assembled monolayers or through covalent crosslinking to nanomaterials. The tiered framework proposed by Li et al. [10] for aquaculture pathogens elegantly illustrates how sandwich ELISA formats can be miniaturized onto electrochemical platforms, with enzyme labels (e.g., horseradish peroxidase or alkaline phosphatase) catalyzing the conversion of a substrate into an electroactive product for amperometric readout. This approach has been successfully applied for the detection of Salmonella Typhimurium and Escherichia coli O157 in potable water with limits of detection below 1 CFU/mL using a non-faradaic impedimetric platform [22]. However, antibodies are subject to denaturation under thermal and chemical stress, motivating the exploration of more robust alternatives.

Nucleic acid aptamers-short, single-stranded DNA or RNA oligonucleotides that fold into specific three-dimensional structures capable of high-affinity target binding-offer superior thermal stability and can be chemically synthesized with exquisite reproducibility [9, 11]. The development of a label-free aptasensor for C. jejuni using a truncated DNA aptamer (ONS-23TA) immobilized onto a MXene/gold nanoparticle hybrid film exemplifies this strategy. The sensor exploited the significant increase in electron transfer resistance upon target binding, achieving a remarkable detection limit of 30 CFU/mL in under 70 minutes [11]. Furthermore, functional nucleic acids (FNAs) have been integrated into isothermal amplification schemes to enhance specificity. For example, peptide nucleic acid (PNA) and locked nucleic acid (LNA) clamping can suppress nonspecific amplification in LAMP assays, while DNAzymes and G-quadruplexes provide catalytic signal amplification for electrochemical readout [4]. The use of RNA-cleaving DNAzymes (RCDs) for the continuous monitoring of Legionella pneumophila in cooling tower water represents a particularly sophisticated implementation, where pathogen-triggered cleavage releases an electroactive DNA barcode that is detected downstream in a microfluidic system [24].

The incorporation of nanomaterials has revolutionized electrochemical sensor performance by dramatically increasing the electrochemically active surface area, enhancing electron transfer kinetics, and providing versatile scaffolds for bioreceptor immobilization. Two-dimensional materials, such as MXenes and laser-induced graphene (LIG), have garnered intense interest due to their exceptional conductivity, large surface-to-volume ratios, and tunable surface chemistries [5, 17, 30, 37]. LIG, formed by direct laser writing on polyimide substrates, enables rapid, maskless fabrication of flexible electrochemical sensors. When functionalized with gold nanostructures (L-Au/LIG), these sensors have been deployed for the real-time monitoring of phenazine production from P. aeruginosa biofilms, revealing over 100-fold higher antibiotic tolerance in biofilm versus planktonic states [12]. Similarly, molybdenum polysulfide (MoSx)-functionalized LIG sensors demonstrated stable, multi-day monitoring of pyocyanin and phenazine-1-carboxylic acid in wound-simulating media, with limits of detection in the sub-micromolar range [13]. Metal-organic frameworks (MOFs) and their derived porous carbons offer high surface areas and tunable pore structures that can be exploited for both pre-concentration of analytes and as scaffolds for enzyme immobilization [3, 7]. Pt-MOF nanozymes, for instance, integrate the catalytic activity of platinum nanoparticles within the MOF matrix, enabling stable, high-performance enzymatic cascade sensing for food safety applications [3]. The synergy between these advanced materials and biorecognition elements is central to achieving the sensitivity demands of real-time veterinary monitoring.

Biological Analytes and the Scope of Veterinary Applications

The application of electrochemical sensors in veterinary medicine must account for an extraordinarily diverse range of analytes, spanning intact viral and bacterial pathogens, their secreted toxins and metabolites, antibiotic residues, and host-derived biomarkers of infection. Each target presents unique challenges in terms of size, surface chemistry, stability, and concentration dynamics.

Direct detection of intact pathogens typically relies on capturing whole cells onto the sensor surface, followed by a signal transduction event. For bacterial pathogens, impedimetric sensors have been highly effective. The binding of Salmonella Typhimurium to antibody-functionalized electrodes, for example, has been monitored in real time using a microfluidic chip with magnetic nanobead chains, achieving detection of 50 CFU/mL in one hour [15]. For viral pathogens, the smaller size and lack of intrinsic redox activity necessitate different strategies. The detection of nucleocapsid proteins or surface glycoproteins using sandwich immunoassays on nanoporous anodic alumina platforms has been demonstrated for Mycobacterium tuberculosis MPT64 antigen, achieving a limit of detection of 1.32 nM in 60 minutes [6]. Extending this to veterinary viruses-such as African Swine Fever Virus, Foot-and-Mouth Disease Virus, Avian Influenza Virus, or Porcine Reproductive and Respiratory Syndrome Virus-is a logical and pressing application. The development of multiplexed panels capable of simultaneously detecting multiple respiratory pathogens, such as Bovine Respiratory Syncytial Virus, Bovine Parainfluenza Virus 3, and Mannheimia haemolytica, would be of immense value for managing bovine respiratory disease complex. Similarly, aquatic pathogens including White Spot Syndrome Virus, Infectious Salmon Anemia Virus, and Koi Herpesvirus demand sensors that can operate in high-salinity, turbid water matrices [10].

Indirect detection via metabolic footprinting offers a complementary strategy, particularly for bacterial and fungal pathogens. This approach targets the specific electroactive metabolites produced during microbial growth. The detection of pyocyanin from P. aeruginosa [12, 13, 20, 26] and the phenazine 5-methylphenazine-1-carboxylic acid (5-MCA) from strain PA14 [20] are archetypal examples. In a veterinary context, the detection of indole produced by E. coli, hydrogen sulfide by Salmonella, or volatile organic compounds indicative of spoilage could provide early warning signs of incipient infection or food contamination [36]. Furthermore, the detection of antibiotic resistance markers is a rapidly growing frontier. Electrochemical sensors capable of detecting beta-lactamase enzymes-using immunostrip formats with 3D hydrogel-paper scaffolds-have been developed for monitoring methicillin-resistant Staphylococcus aureus (MRSA) in human blood cultures, achieving detection limits of 0.146 mU/mL and a turnaround time of one hour [21]. Adapting such platforms to veterinary pathogens like Porcine Circovirus 2 (which often involves co-infections requiring antimicrobial therapy) or detecting extended-spectrum beta-lactamase (ESBL) production in E. coli from dairy cattle is a critical step for antimicrobial stewardship. The integration of these metabolic and resistance markers into a single sensor panel would provide a comprehensive picture of infection status and therapeutic options.

Integration with Microfluidics, IoT, and AI

Transitioning electrochemical sensors from the benchtop to the field necessitates miniaturization and automation. The integration with microfluidic platforms provides precise control over sample volume, fluid flow, and reaction kinetics, enabling automated sample processing and reducing the risk of contamination [17, 24]. The microfluidic BBB-on-a-chip model developed by Ceccarelli et al. [16] demonstrates how EIS can be integrated with thin-film electrodes within a microchannel to monitor barrier integrity in real time, a principle directly transferable to veterinary organ-on-a-chip models for studying pathogen-host interactions. For pathogen detection, microfluidic systems can incorporate upstream sample preparation steps, such as magnetic bead-based capture and concentration, which have been shown to enhance capture efficiency to over 90% for Salmonella [15] and Listeria [2].

The convergence of electrochemical sensing with the Internet of Things (IoT) and artificial intelligence (AI) is enabling the creation of intelligent, networked surveillance systems [1, 8, 27, 33]. IoT-enabled sensors can transmit real-time data on pathogen load, antibiotic concentrations, and environmental parameters (e.g., temperature, humidity) to cloud-based platforms, allowing for remote monitoring and automated alerts [14]. For example, a predictive analytics framework integrating IoT farm sensors with LSTM neural networks has been piloted on Midwestern hog farms, achieving a 22% reduction in antimicrobial use through early intervention [14]. AI algorithms, particularly deep learning models, are being applied to classify electrochemical signals from complex matrices, distinguishing pathogen-specific patterns from background noise [27, 33]. The challenges of data integration and model generalization remain substantial, particularly given the "small-data dilemma" in veterinary applications where outbreak events are sporadic [8]. Nonetheless, the development of robust, field-deployable sensing systems that combine electrochemical transduction, microfluidic automation, and AI-driven analytics represents the pinnacle of current research and the most plausible pathway toward widespread adoption in veterinary practice.

Specific Challenges for Veterinary Deployment

Despite the immense promise, the translation of electrochemical sensors to routine veterinary use is confronted by several formidable challenges. Matrix interference is perhaps the most pervasive obstacle. Whole blood, serum, milk, rumen fluid, feces, and aquaculture water are complex biochemical mixtures replete with proteins, lipids, salts, and other electroactive species that can foul electrode surfaces, generate nonspecific signals, or suppress the target response [29, 34]. The detection of tetracycline residues in milk is especially problematic due to the presence of casein micelles and fat globules that adsorb to electrodes [29]. Strategies to mitigate matrix effects include the use of protective polymer coatings (e.g., Nafion, polypyrrole), the incorporation of sample pre-treatment steps (e.g., filtration, dilution, or magnetic bead-based clean-up), and the employment of ratiometric sensing approaches where an internal standard corrects for matrix-induced signal variations [38].

Sensor calibration drift over extended deployment periods is another critical concern, particularly for continuous monitoring applications in aquaculture tanks or silo storage environments [25, 35]. Electrode fouling from biofilm formation, protein adsorption, or degradation of the biorecognition layer can lead to progressive loss of sensitivity and accuracy. The development of self-calibrating sensors, perhaps using integrated microdosing of calibration standards, or the use of advanced data-driven drift correction algorithms, is an active area of research. Furthermore, the biocompatibility and sterilization of sensors intended for in vivo or minimally invasive use (e.g., in wound dressings or implanted devices) must be rigorously addressed. Electrochemical aptamer-based (EAB) sensors have been shown to retain performance after disinfection with ortho-phthalaldehyde (CIDEX OPA), offering a promising pathway for clinical deployment [19].

Finally, regulatory alignment and standardization remain significant hurdles. The absence of universally accepted performance benchmarks for veterinary electrochemical sensors impedes comparison across studies and hinders adoption by regulatory bodies such as the WOAH (formerly OIE) and national veterinary authorities. Establishing standardized protocols for sensor characterization, including limits of detection, linear range, specificity panels, and long-term stability testing under relevant environmental conditions, is essential for translating laboratory prototypes into commercially viable diagnostic tools. The ultimate success of this technology will depend on its seamless integration into existing veterinary workflows, demonstrating clear cost-benefit advantages over traditional methods, and its ability to provide actionable, real-time data that improves animal health outcomes and safeguards the global food supply.

Molecular Pathogenesis and Target Biomarkers of Key Veterinary Pathogens

The design and deployment of electrochemical sensors for real-time veterinary pathogen monitoring are predicated upon a deep, mechanistic understanding of the molecular pathogenesis of the target microorganisms. This foundational knowledge dictates the selection of appropriate biomarkers-ranging from specific nucleic acid sequences and surface antigens to secreted virulence factors and metabolic byproducts-that serve as the direct analytes for transduction into measurable electrical signals [31, 39]. The molecular interplay between pathogen and host, the temporal dynamics of virulence factor expression, and the biochemical pathways governing pathogen metabolism all inform the rational engineering of sensor interfaces, from the choice of biorecognition element to the optimal signal amplification strategy [8, 32]. An exhaustive comprehension of these pathogenic mechanisms is therefore not merely academic; it is the essential prerequisite for the development of sensors that achieve the requisite specificity, sensitivity, and temporal resolution for clinically actionable, real-time monitoring.

Viral Pathogenesis and Biomarker Selection: From Envelope Proteins to Nucleic Acid Signatures

The molecular pathogenesis of veterinary viruses is fundamentally defined by the processes of host cell attachment, entry, replication, and egress, each stage presenting distinct molecular targets for electrochemical interrogation. For enveloped viruses, the surface glycoproteins mediating host cell receptor binding are primary targets. For instance, the hemagglutinin (HA) and neuraminidase (NA) of Avian Influenza Virus are not only critical for viral entry and release but also serve as the principal antigens for both host immune response and diagnostic detection. The rapid evolution of these glycoproteins, particularly through antigenic drift, presents a significant challenge for sensor design, necessitating the use of broadly reactive antibodies or conserved peptide epitopes for reliable detection across circulating strains [32]. Similarly, the envelope glycoprotein complex (E2) of Classical Swine Fever Virus is essential for virulence and is the target of neutralizing antibodies, making it an excellent candidate for antigen-capture-based electrochemical immunosensors [39]. For Porcine Reproductive and Respiratory Syndrome Virus, the major envelope protein GP5 is a key immunogen, but its high degree of genetic variability complicates universal detection, highlighting the need for assays targeting more conserved structural proteins like the nucleocapsid (N) protein, which is abundantly expressed during infection and is a common target for diagnostic ELISAs [39].

For non-enveloped viruses, the capsid proteins are the primary interface with the host. Foot-and-Mouth Disease Virus, a picornavirus, possesses a highly immunogenic capsid composed of four structural proteins (VP1-VP4). The G-H loop of VP1 is a critical antigenic site and is involved in receptor binding, making it a logical target for serotype-specific detection. However, the existence of seven serotypes and numerous topotypes underscores the need for multiplexed sensor platforms capable of differentiating between them based on distinct epitope signatures [32]. Canine Parvovirus, a single-stranded DNA virus, relies on the VP2 capsid protein for host cell recognition and infection. The emergence of antigenic variants (CPV-2a, 2b, 2c) involves specific amino acid substitutions in VP2 that alter host range and antigenicity, a critical factor for sensor design [32]. Electrochemical genosensors, targeting conserved regions of the VP2 gene, offer a strategy for pan-variant detection, while immunosensors must be carefully characterized for their cross-reactivity profiles [48].

Beyond structural proteins, the detection of viral nucleic acids via electrochemical genosensors provides the ultimate specificity, particularly when targeting conserved non-structural (NS) genes or leader sequences. For African Swine Fever Virus, a complex DNA virus with a massive genome, the detection of highly conserved genes such as p72 (B646L) or p54 (E183L) by isothermal amplification coupled with CRISPR-Cas-based electrochemical readouts is a rapidly advancing field [44]. The integration of recombinase polymerase amplification (RPA) or loop-mediated isothermal amplification (LAMP) with CRISPR/Cas12a or Cas13a systems allows for the generation of a robust electrochemical signal from a single molecule of target DNA, achieving sensitivity that rivals or surpasses real-time PCR without the need for thermal cycling [2, 41, 43]. This is particularly relevant for Infectious Salmon Anemia Virus, where RNA-based detection using CRISPR/Cas13a probes is feasible, or for Koi Herpesvirus, where the detection of latency-associated transcripts can indicate a carrier state [10].

Bacterial Pathogenesis: Targeting Virulence Factors, Metabolism, and Antimicrobial Resistance

Bacterial pathogenesis in veterinary species is a multifaceted process involving adhesion, colonization, toxin secretion, biofilm formation, and immune evasion. Each of these processes yields a distinct class of molecular biomarkers that can be exploited for electrochemical sensing. The detection of secreted virulence factors offers a direct window into the active pathogenic state of the microorganism. The classic example is the detection of pyocyanin, a redox-active phenazine toxin produced by Pseudomonas aeruginosa. This secondary metabolite is not only a key virulence factor in chronic wounds and respiratory infections but is also electrochemically active, enabling its direct, label-free detection at nanomolar concentrations using voltammetric techniques [12, 13, 20, 26]. This capability allows for the real-time monitoring of pathogen metabolism and virulence expression, providing a functional readout of infection dynamics that is impossible with genomic methods alone [33]. Similarly, the electrochemical detection of beta-lactamase enzymes from organisms like methicillin-resistant Staphylococcus aureus (MRSA) provides a functional biomarker for resistance, enabling rapid therapeutic monitoring and stewardship [21].

The molecular basis of adhesion and biofilm formation presents another rich source of biomarkers. The pilus proteins and fimbriae required for attachment to host epithelia are often highly immunogenic and can be targeted by electrochemical immunosensors. For Escherichia coli pathovars, the F4 (K88) or F18 fimbriae are critical for intestinal colonization in piglets and are prime targets for specific detection [39]. Furthermore, the quorum-sensing molecules that orchestrate biofilm formation, such as N-acyl homoserine lactones (AHLs) in Gram-negative pathogens or autoinducing peptides (AIPs) in Gram-positive species, can serve as early-warning biomarkers for biofilm development. Electrochemical sensors functionalized with specific receptors for these signaling molecules can provide a preemptive alert before a mature, antibiotic-tolerant biofilm is established [35, 45]. The host immune response itself can be tracked by detecting specific antibodies produced against these bacterial components. Serological detection of antibodies to Brucella abortus lipopolysaccharide or to the gp51 envelope protein of Bovine Leukemia Virus are established methods where electrochemical transduction can offer a rapid, point-of-care alternative to traditional ELISA tests [39].

The detection of antimicrobial resistance (AMR) genes and their products is a paramount application for electrochemical sensors. The molecular mechanisms of resistance-enzymatic inactivation (e.g., beta-lactamases, aminoglycoside-modifying enzymes), target modification (e.g., mecA-encoded PBP2a in MRSA), or efflux pumps (e.g., tet genes for tetracyclines)-all provide specific nucleic acid or protein targets. Electrochemical genosensors capable of detecting mecA, vanA (vancomycin resistance), or blaCTX-M (extended-spectrum beta-lactamase) directly from clinical or environmental samples offer a significant advantage over culture-based susceptibility testing, reducing turnaround time from days to hours [39, 47]. The integration of such sensors into a predictive analytics framework, utilizing IoT-enabled farm sensors and machine learning algorithms, can create a powerful surveillance network for AMR emergence in livestock populations, enabling proactive stewardship interventions as demonstrated in pilot deployments on swine farms [14].

Aquatic Pathogen Pathogenesis: Unique Challenges and Biomarkers

The monitoring of pathogens in aquaculture presents unique challenges due to the aqueous environment, which dilutes biomarkers and complicates sample processing. The molecular pathogenesis of aquatic viruses often involves rapid replication in key hematopoietic tissues or the nervous system. For White Spot Syndrome Virus, the major structural proteins VP28 and VP19 are highly antigenic and are the primary targets for immunodiagnostic assays. However, the latency of aquatic viruses complicates detection. For Channel Catfish Virus, a herpesvirus, latency is established in sensory neurons, and detection requires sensitive nucleic acid-based assays targeting immediate-early (IE) genes that are expressed during reactivation [10]. The detection of extracellular vesicles (EVs), which have been shown to carry viral components and facilitate cross-species immune dialogue in the aquatic environment, represents a novel and potentially powerful biomarker paradigm for a One Health approach [42].

For bacterial pathogens in aquaculture, such as Vibrio spp. or Aeromonas spp., the detection of specific toxins or quorum-sensing molecules is highly informative. The development of immunoassay-based biosensing platforms, structured into a tiered framework for lab-based, field-deployable, and continuous monitoring applications, is critical. For instance, portable lateral flow immunoassays (LFIAs) for VP28 of WSSV are now being complemented by emerging electrochemical immunosensors capable of near-real-time data transmission. The detection of the capsid protein of Infectious Pancreatic Necrosis Virus or the glycoprotein of Viral Hemorrhagic Septicemia Virus can be achieved with high sensitivity using nanomaterial-enhanced electrochemical platforms, providing a crucial tool for biosecurity in hatcheries and grow-out facilities [10].

Zoonotic and Emerging Pathogens: Bridging Veterinary and Public Health

The molecular pathogenesis of zoonotic pathogens directly links animal health to public health, making their real-time detection a critical One Health priority. The highly pathogenic West Nile Virus, an arbovirus, replicates efficiently in birds, leading to high viremia that facilitates transmission to mosquitoes and subsequently to humans and horses. The detection of the viral envelope (E) protein in avian sera or oral swabs via electrochemical sensors can serve as a sentinel system for viral circulation, providing an early warning for potential human outbreaks [39]. Similarly, the detection of Salmonella enterica serovars, particularly those associated with poultry and livestock, requires not only species-level identification but also serotyping and genotyping for epidemiological tracking. The O-antigen and H-antigen of Salmonella lipopolysaccharide and flagella are classical serotyping targets that can be integrated into multiplexed electrochemical platforms [22, 32]. The development of phage tail spike protein-based magnetic separation (T-MS) techniques allows for the rapid and specific capture of viable Salmonella cells from complex food matrices, which can then be detected by downstream electrochemical or ATP-bioluminescence assays, significantly reducing detection time compared to culture [40].

The threat of emerging viruses like Nipah Virus In Pigs or Rift Valley Fever Virus underscores the need for agile diagnostic platforms that can be rapidly deployed. The surface glycoproteins (G and F for Nipah; Gn and Gc for RVFV) are the primary targets for neutralizing antibodies and are thus key for antigen detection. The development of universally applicable sensor scaffolds, such as those based on molecularly imprinted polymers (MIPs) that can be templated against any virus particle, offers a promising route to rapid sensor development against novel pathogens [46]. The profound impact of Rabies Lyssavirus, a neurotropic RNA virus, on both animal and human health makes rapid antemortem diagnosis a critical need. Detection of viral nucleoprotein in saliva or corneal impressions using electrochemical sensors could provide a faster and more accessible alternative to the gold-standard direct fluorescent antibody test on brain tissue, enabling earlier post-exposure prophylaxis interventions [39]. For West Nile Virus In Wild Birds and other wildlife viruses, non-invasive sampling (e.g., feces, feathers) combined with highly sensitive sensor systems can facilitate population-level surveillance without the stress and risk of capture, providing invaluable data for ecosystem health monitoring.

In summary, the molecular pathogenesis of veterinary pathogens is a vast and intricate landscape that directly dictates the selection of target biomarkers for electrochemical sensor development. Whether targeting the structural proteins of a rapidly mutating influenza virus, the redox-active exoproducts of a biofilm-forming bacterium, or the conserved genomic sequences of an emerging aquatic pathogen, the sensor design must be intimately informed by the underlying biology. The successful translation of these sensors from research laboratories into field-deployable, real-time monitoring systems will hinge on a continued, exhaustive dialogue between veterinary pathologists, molecular biologists, and electrochemical sensor engineers.

Electrochemical Transduction Mechanisms and Sensor Design Strategies

The translation of a biorecognition event into a quantifiable electrical signal constitutes the foundational architecture of any electrochemical sensor deployed for real-time veterinary pathogen monitoring. For the veterinary clinical pathologist, understanding these transduction mechanisms is paramount, as the choice of modality-amperometric, potentiometric, impedimetric, or voltammetric-dictates the sensor's temporal resolution, sensitivity, and compatibility with complex biological matrices such as whole blood, serum, milk, or fecal homogenates. This section delineates the core electrochemical principles, examines the sophisticated design strategies employed to maximize signal fidelity, and contextualizes their application within the demanding landscape of point-of-care and continuous monitoring paradigms in veterinary medicine.

Fundamental Electrochemical Transduction Modalities

Amperometric and Voltammetric Sensing: Direct and Mediated Electron Transfer

Amperometric sensors operate by measuring the current generated during the oxidation or reduction of an electroactive species at a working electrode held at a constant potential. This modality is exceptionally well-suited for detecting redox-active metabolites directly produced by pathogens. A paradigmatic example is the real-time monitoring of phenazine toxins secreted by Pseudomonas aeruginosa. Specifically, pyocyanin (PYO) and phenazine-1-carboxylic acid (PCA) are electroactive virulence factors that can be directly oxidized at modest potentials, enabling their quantification without the need for exogenous labels. Studies utilizing transparent carbon ultramicroelectrode arrays (T-CUAs) have demonstrated the capacity to track PYO and 5-methylphenazine-1-carboxylic acid (5-MCA) dynamics over 48-hour growth periods, revealing concentration plateaus and subtle decreases that correlate with bacterial metabolic shifts [20]. This approach has been extended to flexible biosensor platforms for wound monitoring, where the detection of PYO, uric acid, and nitric oxide provides a multiparametric assessment of infection and host immune responses [26].

To expand the repertoire of detectable targets beyond native electroactive species, mediated amperometry employs redox-active compounds as shuttles between the biorecognition element and the electrode surface. For instance, glucose oxidase (GOx) immobilized on a sensor surface generates hydrogen peroxide in the presence of glucose, which is subsequently oxidized at the electrode. In a sophisticated microfluidic system for Salmonella detection, immune polystyrene microspheres decorated with GOx were integrated into a sandwich immunoassay. The enzymatic production of gluconic acid and hydrogen peroxide from a non-conductive glucose substrate induced a measurable impedance change, achieving a detection limit of 50 CFU/mL within one hour [15]. This strategy elegantly couples the high specificity of immunological recognition with the signal amplification inherent to enzymatic catalysis.

Voltammetric techniques, particularly differential pulse voltammetry (DPV) and square wave voltammetry (SWV), offer superior sensitivity compared to classical amperometry by minimizing capacitive charging currents. These methods are indispensable for detecting antibiotic residues and other small-molecule contaminants. A graphene oxide/multi-walled carbon nanotube (GO@MWCNT) nanocomposite sensor, integrated with a smartphone-based potentiostat, achieved a limit of detection (LOD) of 46 nM for chloramphenicol (CAP) in milk, serum, and environmental water samples [49]. The DPV signal provided excellent stability, with 90% signal retention after 21 days, and the platform demonstrated strong correlation with laboratory-grade instrumentation, validating its utility for field-deployable screening in veterinary practice.

Potentiometric Sensing: Ion-Selective Electrodes and Field-Effect Transistors

Potentiometric sensors measure the accumulation of charge potential at an electrode surface under zero current flow, providing a logarithmic response to analyte activity. Ion-selective electrodes (ISEs) are the archetypal potentiometric devices, but their application to pathogen detection is often indirect, focusing on metabolic byproducts such as pH changes or ammonium ions. A more transformative potentiometric architecture for real-time monitoring is the field-effect transistor (FET). In a FET-based biosensor, the binding of a charged target analyte to a bioreceptor immobilized on the gate dielectric modulates the source-drain current. The intrinsic vertical polarization of Janus transition metal dichalcogenides (J-TMDCs), such as Janus MoSSe, creates a built-in electric field that can dramatically enhance the sensitivity of FET-based detection [5]. While electrochemical and FET applications of J-TMDCs remain largely theoretical in the context of pathogen sensing, their potential for label-free, ultrasensitive detection of viral surface proteins or nucleic acids is profound and warrants active investigation for veterinary diagnostics.

Electrochemical Impedance Spectroscopy (EIS): Label-Free Interfacial Probing

EIS is arguably the most versatile and information-rich electrochemical transduction method for pathogen monitoring. By applying a small-amplitude sinusoidal potential over a range of frequencies and measuring the resulting current, EIS deconvolves the resistive and capacitive components of the electrode-electrolyte interface. The technique is exquisitely sensitive to changes in interfacial architecture-such as the binding of bacterial cells, the formation of a biofilm, or the enzymatic cleavage of a surface-immobilized substrate.

The power of EIS for rapid pathogen detection was demonstrated using disposable screen-printed carbon electrodes to monitor Proteus mirabilis growth. A normalization approach, comparing the charge transfer resistance (Rct) at each time point to an initial baseline, allowed detection of bacterial growth within 1 hour of inoculation at a concentration of 7.4 x 10^6 CFU/mL [18, 51]. The decrease in Rct was directly attributable to bacterial metabolic activity, as experiments in non-growth saline showed no such impedance change. This differentiation between metabolic and non-metabolic signals is critical for veterinary applications, where the distinction between viable, actively dividing pathogens and inert contaminants informs treatment decisions.

Further illustrating the depth of EIS, a two-plex platform for simultaneous detection of Salmonella Typhimurium and Escherichia coli O157 achieved LODs of 0.8 and 0.9 CFU/mL, respectively, in potable water within a 5-minute turnaround time [22]. The non-faradaic impedance approach, which avoids the use of redox probes, simplifies the sensor architecture and enhances its robustness for field use. Such rapid, multiplexed detection is of paramount importance in livestock settings, where point-of-care identification of agents like Porcine Reproductive and Respiratory Syndrome Virus or Bovine Viral Diarrhea Virus can dictate immediate biosecurity interventions.

Advanced Sensor Design Strategies for Enhanced Performance

Nanomaterial-Mediated Signal Amplification and Electrode Functionalization

The sensitivity of electrochemical sensors is fundamentally limited by the efficiency of electron transfer at the electrode surface. Nanomaterials, with their high surface-area-to-volume ratios and unique electronic properties, provide a direct route to overcome this limitation. Platinum-based metal-organic frameworks (Pt-MOFs) represent a cutting-edge class of nanozymes that integrate the high catalytic activity of Pt nanoparticles within the porous, tunable framework of MOFs. These hybrid materials exhibit synergistic catalytic mechanisms, including electronic synergy between Pt and the MOF ligand, spatial confinement of substrates, and cooperative active-site interactions [3]. Pt-MOFs have been employed in immunosensing and aptasensing platforms for foodborne pathogens, offering enhanced stability and sensitivity compared to natural enzymes.

Two-dimensional (2D) materials, including MXenes (transition metal carbides/nitrides) and MBenes (transition metal borides), have emerged as formidable electrode modifiers. MXenes, with their metallic conductivity, hydrophilic surface terminations, and ease of solution processing, are particularly promising. A label-free aptasensor for Campylobacter jejuni utilized a hybrid film of electrodeposited gold nanoparticles and MXene on a carbon screen-printed electrode. The MXene/AuNP composite significantly enhanced electron transfer, enabling a wide linear detection range (10^2 to 10^10 CFU/mL) with a remarkable LOD of 30 CFU/mL within 70 minutes [11]. The high selectivity against non-target bacteria, even at three-orders-of-magnitude higher concentrations, underscores the specificity achievable when nanomaterials are combined with high-affinity aptamers.

Laser-induced graphene (LIG), fabricated by direct laser scribing of polyimide substrates, offers a scalable and cost-effective route to flexible, three-dimensional graphene electrodes. LIG functionalized with molybdenum polysulfide (MoSx) via electrodeposition provided a stable platform for real-time monitoring of Pseudomonas aeruginosa biofilms over several days [13]. The MoSx functionalization decreased the LOD for pyocyanin to 0.19 microM and enabled the distinction between time-dependent phenazine production in different sensor configurations ("Normal" vs. "Flipped"), offering insights into how cell-sensor geometry influences signal dynamics. Direct laser functionalization of LIG with gold nanostructures (L-Au/LIG) further improved sensitivity (1.205 microA microM^-1) while avoiding the bactericidal effects observed with electroless gold deposition, making L-Au/LIG suitable for in situ antibiotic susceptibility testing [12].

Biorecognition Element Engineering: Aptamers, Molecularly Imprinted Polymers, and Functional Nucleic Acids

The biorecognition element is the molecular interface that confers selectivity. While antibodies remain the gold standard, their batch-to-batch variability and susceptibility to thermal denaturation have driven the adoption of alternative recognition elements. Aptamers-single-stranded DNA or RNA oligonucleotides selected in vitro-offer superior stability, low cost, and the ability to discriminate between closely related analytes, including chiral enantiomers [9]. For veterinary applications, aptamers have been developed against surface proteins of Avian Influenza Virus and Newcastle Disease Virus, enabling label-free electrochemical detection with minimal sample preparation.

Molecularly imprinted polymers (MIPs) provide another robust alternative. These synthetic polymers are templated around a target analyte, creating specific binding cavities that mimic the shape and functional group arrangement of antibodies. MIP-based electrochemical sensors (MI-ECSs) exhibit high selectivity and chemical stability, making them ideal for detecting small-molecule contaminants like mycotoxins and antibiotic residues in complex food matrices [46]. The integration of MIPs with screen-printed electrodes offers a clear pathway to disposable, low-cost sensors for on-farm screening of aflatoxin B1 in grain storage, a critical need for livestock feed safety [25].

Functional nucleic acids (FNAs) are revolutionizing isothermal amplification-based sensors. FNAs such as DNAzymes, G-quadruplexes, and i-motifs serve as both recognition and signal transduction elements. For instance, RNA-cleaving DNAzymes (RCDs) incorporated into a microfluidic platform enable continuous, real-time detection of Legionella pneumophila in cooling tower water. The RCD cleaves a substrate in the presence of the target pathogen, releasing an electroactive DNA barcode that is detected downstream by an electrochemical sensor [24]. This system achieves a LOD of 1.9 x 10^3 CFU/mL in real-world water samples and can distinguish between L. pneumophila serotypes, demonstrating the power of integrating catalytic nucleic acids with microfluidics for continuous veterinary and environmental surveillance.

Microfluidic Integration and Multi-Plexing Architectures

The translation of electrochemical sensors from benchtop to bedside requires seamless integration with fluid handling systems. Microfluidic platforms miniaturize sample processing, reduce reagent consumption, and enable precise temporal control over multi-step assays. A two-stage microfluidic device for L. pneumophila detection incorporates magnetic microgel beads decorated with RCDs, a downstream electrochemical detection chamber, and continuous flow of cooling tower water [24]. The system identifies key parameters-peak current, slope of signal increase, and lag time-that correlate with bacterial concentration, providing a rich dataset for real-time risk assessment.

For multiplexed detection, which is essential for syndromic panels in veterinary diagnostics, electrochemical arrays with individually addressable working electrodes are employed. A portable, non-faradaic two-plex sensor for Salmonella and E. coli utilized targeted antibodies immobilized on distinct electrode spots, achieving LODs below 1 CFU/mL with a total assay time of 5 minutes [22]. The inter-study and intra-study coefficients of variation remained below 20%, confirming the reproducibility necessary for regulatory compliance. Such platforms are directly translatable to panels targeting African Swine Fever Virus, Classical Swine Fever Virus, and Foot-and-Mouth Disease Virus, which require rapid differential diagnosis during outbreak investigations.

Addressing Matrix Interference and Ensuring Robustness

One of the principal challenges in veterinary electrochemical sensing is the complexity of biological matrices. Milk, for example, contains fats, proteins, and minerals that can nonspecifically adsorb to electrodes and foul the surface. Strategies to mitigate these effects include the use of protective polymer membranes, such as polypyrrole:polystyrene sulfonate (PPy:PSS), which was shown to stabilize impedance measurements for fucosyltransferase activity monitoring by minimizing electrode fouling [50]. Pre-treatment steps, such as dilution, filtration, or magnetic enrichment using functionalized beads, are also effective. A tail spike protein-based magnetic separation (T-MS) approach using engineered phage proteins captured 80-90% of Salmonella cells from milk, lettuce, and pork, enabling subsequent ATP-bioluminescence detection with recovery rates of 95-107% [40]. The integration of such clean-up modules upstream of the electrochemical transducer is a critical design consideration for real-world deployment.

Furthermore, the issue of sensor disinfection and sterilization, particularly for sensors intended for long-term implantable or wearable use, cannot be overlooked. Electrochemical aptamer-based (EAB) sensors, which provide seconds-resolved, real-time measurement of drugs and metabolites in vivo, were found to tolerate disinfection with 0.55% ortho-phthalaldehyde (CIDEX OPA) without significant degradation, whereas many other sterilization methods led to sensor failure [19]. This finding is crucial for veterinary applications such as continuous monitoring of antibiotic levels in livestock or tracking biomarkers in companion animals with chronic wounds.

In summary, the field of electrochemical transduction for veterinary pathogen monitoring is advancing rapidly, driven by innovations in nanomaterial science, biorecognition element engineering, and microfluidic integration. From the direct voltammetric detection of redox-active virulence factors to the label-free impedimetric monitoring of bacterial growth, and from the exquisite selectivity of aptamers and MIPs to the continuous sensing enabled by RCD-based platforms, the toolset available to the veterinary clinical pathologist is expanding. The next frontier lies in the robust translation of these laboratory-proven architectures into field-deployable, low-cost devices that can withstand the rigors of on-farm use and deliver clinically actionable data in real time.

Protocol and Methodology for On-Site Veterinary Pathogen Detection

The translation of electrochemical sensor technology from the research laboratory to the field-whether that field is a commercial poultry house, a remote aquaculture facility, a livestock auction barn, or a companion animal clinic-demands a rigorous, standardized, and application-specific protocol framework. Unlike centralized laboratory diagnostics, where sample integrity, environmental conditions, and operator expertise can be tightly controlled, on-site veterinary pathogen detection operates under constraints of variable temperature, humidity, dust, biological matrix complexity, and operator skill levels. The protocol and methodology for these deployments must therefore be designed with an inherent robustness that accounts for these variables while maintaining analytical performance comparable to gold-standard methods. This section delineates the comprehensive procedural architecture required for successful implementation of electrochemical sensing platforms in veterinary field settings, drawing upon the latest advances in sample preparation, nucleic acid amplification, biorecognition integration, signal transduction, and data interpretation.

Pre-Analytical Phase: Sample Collection, Stabilization, and Pre-Processing

The pre-analytical phase is arguably the most critical determinant of assay success in on-site veterinary diagnostics. Biological specimens from veterinary patients-including whole blood, serum, nasal swabs, fecal samples, tissue homogenates, milk, urine, and environmental water samples-present unique challenges related to viscosity, particulate matter, inhibitory substances, and target analyte lability. For electrochemical sensors targeting pathogen nucleic acids, proteins, or whole cells, the protocol must begin with a standardized collection procedure that minimizes degradation and maximizes target recovery.

For whole-cell pathogen detection, such as the identification of Salmonella Typhimurium in livestock feces or Escherichia coli O157 in water sources, immunomagnetic separation (IMS) has emerged as a powerful front-end concentration strategy. The use of engineered phage tail spike proteins (TSPs) for magnetic separation, as demonstrated by Choi et al. [40], offers a paradigm shift in capture specificity. In this approach, a catalytically inactivated mutant of the SFP10 phage tail spike protein, fused with a silica-binding domain, is immobilized on magnetic beads. This TSP-based magnetic separation (T-MS) achieves 80-90% capture efficiency of Salmonella cells directly from complex food matrices such as milk, lettuce, and pork within 30 minutes [40]. For on-site veterinary applications, this protocol eliminates the need for lengthy enrichment cultures, allowing direct processing of fecal or environmental samples. Similarly, the integration of core-shell structured Fe3O4@UiO-66-NH2 metal-organic frameworks (MOFs) for bacterial enrichment, as reported by Lan et al. [2], achieves over 90% capture efficiency for multiple foodborne pathogens simultaneously, a critical feature for syndromic surveillance in livestock operations where co-infections are common.

When the target is nucleic acid-for viral pathogens such as Avian Influenza Virus, African Swine Fever Virus, or Porcine Reproductive and Respiratory Syndrome Virus-the pre-analytical protocol must include efficient lysis and nucleic acid stabilization. Field-deployable lysis buffers containing chaotropic agents (e.g., guanidinium thiocyanate) and detergents (e.g., SDS or Triton X-100) are essential for inactivating nucleases and releasing target DNA or RNA. For RNA viruses, such as Infectious Salmon Anemia Virus or Salmonid Alphavirus, the inclusion of RNase inhibitors in the lysis buffer is non-negotiable. The protocol should specify a rapid, room-temperature lysis step of 5-10 minutes, followed by a brief centrifugation or filtration to remove debris, yielding a crude lysate suitable for direct amplification.

For electrochemical sensors targeting secreted protein biomarkers, such as the MPT64 antigen of Mycobacterium tuberculosis in bovine tuberculosis screening, the sample matrix must be clarified to prevent fouling of the sensor surface. Caballos et al. [6] demonstrated that a simple centrifugation step at 10,000 x g for 10 minutes, followed by filtration through a 0.22 micron membrane, is sufficient to prepare clinical samples for analysis on a gated nanoporous anodic alumina biosensor. This protocol achieves a limit of detection (LOD) of 1.32 nM for MPT64 within 60 minutes, with high selectivity against other mycobacterial species and viral antigens [6]. For veterinary applications, this approach could be adapted for milk, serum, or tissue homogenates, provided that the matrix is pre-diluted in a compatible buffer (e.g., phosphate-buffered saline with 0.1% bovine serum albumin) to reduce non-specific binding.

Amplification and Signal Generation: Isothermal Strategies for Field Deployment

The heart of any nucleic acid-based electrochemical sensor is the amplification strategy. While polymerase chain reaction (PCR) remains the gold standard for sensitivity and specificity, its requirement for thermal cycling equipment limits its utility in true point-of-care (POC) settings. Portable real-time PCR systems have been developed, such as the device described by Lee et al. [52], which employs a two-stage amplification strategy and achieves LODs of 6.0 x 10^1 to 3.0 x 10^1 CFU/mL for airborne bacteria within 2 hours. However, for ultra-rapid field diagnostics, isothermal amplification methods-particularly loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA)-offer superior speed and simplicity.

The protocol for LAMP-based electrochemical detection must address the unique challenges of primer design, reaction optimization, and amplicon detection. Silva et al. [43] provide a comprehensive framework for LAMP-CRISPR diagnostics, emphasizing that the design of LAMP primers requires careful consideration of target sequence conservation, GC content, and secondary structure formation. For veterinary pathogens, the target region should ideally be a highly conserved gene or genomic region to ensure detection across multiple strains or serotypes. For example, the invA gene for Salmonella spp., the hlyA gene for Listeria monocytogenes, or the VP2 gene for Canine Parvovirus are well-established targets. The protocol should specify a LAMP reaction temperature of 60-65 degrees C, typically maintained using a simple heat block or battery-powered incubator, with a reaction time of 30-45 minutes.

The integration of CRISPR/Cas systems, particularly Cas12a and Cas13, with isothermal amplification has revolutionized on-site detection by providing sequence-specific cleavage activity that generates a detectable signal. The RPA-CRISPR/Cas12a platform described by Lan et al. [2] and Jeong et al. [41] exemplifies this approach. In the protocol, RPA primers are designed to amplify a target-specific amplicon within 20-30 minutes at a constant temperature of 37-42 degrees C. The resulting amplicon activates the Cas12a nuclease, which then cleaves a fluorophore-quencher reporter probe, generating a fluorescence signal that can be read by a smartphone camera or a portable fluorometer. For electrochemical readout, the trans-cleavage activity of Cas12a can be coupled to an electrode surface modified with a DNA probe; cleavage of the probe alters the electrochemical impedance or current, providing a quantitative signal [41, 43]. The protocol must include a careful optimization of the Cas12a guide RNA (crRNA) concentration, the reporter probe concentration, and the reaction time to maximize signal-to-noise ratio while minimizing non-specific cleavage.

For veterinary applications targeting RNA viruses, such as Avian Influenza Virus or Newcastle Disease Virus, the protocol must incorporate a reverse transcription step prior to RPA or LAMP. This can be achieved by including a reverse transcriptase enzyme (e.g., AMV-RT or M-MLV-RT) in the reaction mix, converting the RNA target to cDNA within 10-15 minutes at 42 degrees C. The entire workflow-from sample lysis to signal readout-can be completed in under 60 minutes, as demonstrated by Jeong et al. [41] for airborne foodborne pathogens, achieving LODs of 4.5-274.9 CFU/mL.

Electrochemical Transduction and Sensor Architecture

The choice of electrochemical transduction method is dictated by the target analyte (nucleic acid, protein, whole cell, or metabolite) and the desired sensitivity, specificity, and time resolution. The three most common modalities in veterinary POC sensors are amperometry, potentiometry, and electrochemical impedance spectroscopy (EIS).

For amperometric sensors, the protocol involves applying a fixed potential to the working electrode and measuring the current generated by the oxidation or reduction of an electroactive species. This approach is particularly well-suited for detecting redox-active metabolites produced by pathogens, such as the phenazine pyocyanin secreted by Pseudomonas aeruginosa. Simoska et al. [20] and Zhou et al. [12, 13] have developed protocols using transparent carbon ultramicroelectrode arrays (T-CUAs) and laser-induced graphene (LIG) electrodes functionalized with molybdenum polysulfide (MoSx) or gold nanostructures for real-time monitoring of pyocyanin production. The protocol specifies a square wave voltammetry (SWV) scan from -0.6 V to +0.2 V (vs. Ag/AgCl), with a step potential of 5 mV and a frequency of 15 Hz. The oxidation peak of pyocyanin at approximately -0.25 V is quantified, achieving an LOD of 0.19 microM in wound-simulating medium [13]. For veterinary wound monitoring or mastitis detection in dairy cattle, this protocol enables continuous, non-invasive tracking of infection progression.

For potentiometric sensors, the protocol measures the potential difference between a working electrode and a reference electrode under zero current conditions. Ion-selective electrodes (ISEs) and field-effect transistors (FETs) are common potentiometric platforms. The protocol for a potentiometric aptasensor targeting Campylobacter jejuni, as developed by Tertis et al. [11], involves immobilizing a thiolated DNA aptamer on a gold nanoparticle/MXene-modified screen-printed carbon electrode. After blocking with mercaptohexanol to prevent non-specific adsorption, the sensor is incubated with the sample for 30 minutes. The binding of C. jejuni cells to the aptamer alters the interfacial electron transfer resistance, which is measured by EIS in the presence of a [Fe(CN)6]3-/4- redox probe. The protocol achieves a wide linear range of 10^2 to 10^10 CFU/mL with an LOD of 30 CFU/mL within 70 minutes [11]. This approach is highly adaptable for other bacterial pathogens of veterinary significance, such as Salmonella spp., E. coli O157, and Staphylococcus aureus.

Impedimetric sensors, which measure the complex impedance of the electrode-electrolyte interface over a range of frequencies, are particularly sensitive to changes in surface capacitance and charge transfer resistance caused by biomolecular binding events. The protocol for EIS-based detection typically involves a frequency sweep from 0.1 Hz to 100 kHz with an AC amplitude of 10-50 mV. Neubauer et al. [35] deployed microfabricated interdigitated electrode arrays in river water for biofilm detection, fitting the EIS data to a Randles circuit with a constant phase element (CPE). The CPE magnitude was tracked over 600 hours, showing a gradual increase that correlated with biofilm formation [35]. For veterinary applications, this protocol can be adapted for real-time monitoring of bacterial growth in wound dressings, as demonstrated by Hannah et al. [18, 51], who used EIS to detect Proteus mirabilis and Pseudomonas aeruginosa in simulated wound fluid within 1 hour of inoculation.

Multiplexing and Panel Design for Syndromic Surveillance

Veterinary clinical presentations are rarely caused by a single pathogen; respiratory disease complexes in cattle (involving Bovine Respiratory Syncytial Virus, Bovine Herpesvirus 1, Bovine Viral Diarrhea Virus, and Mannheimia haemolytica), enteric disease in swine (involving Porcine Epidemic Diarrhea Virus, Transmissible Gastroenteritis Virus, and E. coli), and respiratory disease in poultry (involving Infectious Bronchitis Virus, Avian Metapneumovirus, and Ornithobacterium rhinotracheale) demand multiplexed detection capabilities.

The protocol for multiplexed electrochemical detection must address spatial separation of biorecognition elements, cross-reactivity, and differential signal readout. The two-plex non-faradaic electrochemical platform described by Mishra et al. [22] for simultaneous detection of Salmonella Typhimurium and E. coli O157 in potable water achieves LODs of 0.8 and 0.9 CFU/mL, respectively, within 5 minutes. The protocol involves immobilizing target-specific antibodies on separate working electrodes within a single screen-printed array, followed by EIS measurement. The inter-study and intra-study coefficients of variation remained below 20%, demonstrating robust reproducibility [22].

For nucleic acid-based multiplexing, the quadruplex RPA-CRISPR/Cas12a platform developed by Lan et al. [2] provides a template for veterinary applications. The protocol uses four distinct crRNAs, each specific to a different pathogen (e.g., Salmonella Typhimurium, Staphylococcus aureus, Vibrio parahaemolyticus, and Listeria monocytogenes), with each crRNA activating a Cas12a nuclease that cleaves a unique fluorophore-quencher reporter. The fluorescence signals are read using a smartphone camera with a custom filter attachment, enabling quantitative, objective readouts within 60 minutes [2]. For veterinary use, this panel could be adapted to target the most prevalent pathogens in a given production system-for example, a swine respiratory panel targeting Porcine Reproductive and Respiratory Syndrome Virus, Swine Influenza A Virus, and Mycoplasma hyopneumoniae.

Quality Control, Calibration, and Data Interpretation

The reliability of on-site electrochemical sensors hinges on rigorous quality control (QC) protocols. For each batch of sensors, the protocol must include calibration with a known standard (e.g., a synthetic DNA oligonucleotide for nucleic acid sensors, or a purified protein for immunosensors) to establish the baseline signal and calculate the LOD and linear dynamic range. For the MXene-based aptasensor developed by Tertis et al. [11], the calibration curve is constructed by plotting the charge transfer resistance (Rct) against the logarithm of C. jejuni concentration, yielding a linear response from 10^2 to 10^10 CFU/mL. The protocol specifies that each calibration point should be measured in triplicate, with the relative standard deviation (RSD) not exceeding 5%.

Internal positive and negative controls are essential for validating assay performance in the field. For RPA-CRISPR assays, a positive control consisting of a synthetic target sequence (e.g., a gBlocks gene fragment) should be included in each run to confirm amplification and cleavage activity. A negative control (nuclease-free water) is used to assess non-specific signal generation. The protocol should define a threshold for positivity-for example, a signal-to-noise ratio greater than 3.0-to minimize false positives.

Data interpretation in the field must account for matrix effects, sensor drift, and environmental interference. For electrochemical sensors deployed in complex biological matrices such as milk, blood, or fecal homogenates, the protocol should include a matrix-matched calibration or a standard addition method. Raykova et al. [29] highlight that the milk matrix, with its high protein and fat content, can significantly alter the electrochemical response, necessitating pre-dilution or the use of a blocking agent such as bovine serum albumin. For real-time monitoring applications, such as the continuous tracking of pyocyanin in wound dressings, the protocol should include baseline subtraction to correct for sensor drift over time [12, 13].

Integration with IoT and AI for Intelligent Surveillance

The final layer of the protocol involves the integration of electrochemical sensors with Internet of Things (IoT) infrastructure and artificial intelligence (AI) for automated data acquisition, transmission, and decision support. The protocol for IoT-enabled veterinary pathogen monitoring, as outlined by Priyadharsshini et al. [1] and Akinyemi et al. [14], specifies the use of low-power microcontrollers (e.g., ESP32 or Arduino-based systems) to control sensor operation, log data, and transmit results via Wi-Fi, Bluetooth, or LoRaWAN to a cloud-based platform. The Data Acquisition Station (DAQ) described by Neubauer et al. [35] uses a single-board computer to control an impedance spectroscope, with data retrieval via Wi-Fi for large datasets and LoRa for status updates over distances up to 32 km in rural areas.

AI algorithms, particularly machine learning models such as Long Short-Term Memory (LSTM) networks and Random Forest classifiers, can be integrated into the protocol for predictive analytics. Zhao et al. [27] review how AI enhances electrochemical sensing by improving signal processing, reducing noise, and enabling multiplexed data interpretation. For veterinary applications, the protocol could include a trained model that analyzes impedance spectra or voltammograms in real time, classifying samples as positive or negative for a specific pathogen with a confidence score. Akinyemi et al. [14] demonstrated that an LSTM-based forecasting model achieved a

Clinical Application and Performance in Livestock and Companion Animal Settings

The translation of electrochemical sensor technology from benchtop prototypes to clinically actionable tools within veterinary practice represents a pivotal frontier in animal health management. Unlike human medicine, where centralized clinical laboratories dominate, veterinary diagnostics-particularly in livestock operations and companion animal clinics-demand rapid, cost-effective, and field-deployable solutions that can interface directly with the biological realities of diverse species. The clinical application of these sensors must contend with species-specific pathophysiology, variable sample matrices (e.g., milk, blood, wound exudate, saliva, and environmental water), and the pressing need for real-time pathogen surveillance to mitigate both endemic disease and zoonotic spillover. This section critically examines the performance, integration challenges, and translational potential of electrochemical sensing platforms across livestock and companion animal settings, drawing on a wealth of recent literature to contextualize their clinical utility.

Point-of-Care Pathogen Detection in Livestock: From Stables to Feedlots

In intensive livestock production, the economic and welfare consequences of undetected pathogen outbreaks are catastrophic. The ability to deploy electrochemical sensors for on-site detection of bacterial and viral pathogens directly addresses the latency inherent in culture-based methods and centralized PCR. For instance, the development of a label-free electrochemical aptasensor for Campylobacter jejuni-the leading bacterial cause of foodborne gastroenteritis in the European Union and a significant pathogen in poultry and cattle-demonstrates a limit of detection (LOD) of 30 CFU/mL using a hybrid gold nanoparticle/MXene nanocomposite on screen-printed carbon electrodes [11]. This performance is clinically relevant, as C. jejuni loads in contaminated carcasses or environmental samples often fall within this range. The 70-minute total assay time, compared to 48-72 hours for culture, enables real-time decision-making at the slaughterhouse or farm level, potentially intercepting contaminated product before it enters the supply chain. Similarly, a magnetic nanobead chain-assisted impedance sensor for Salmonella Typhimurium achieved a detection limit of 50 CFU/mL within 1 hour, leveraging glucose oxidase-mediated signal amplification on a PCB interdigitated electrode within a microfluidic chip [15]. This platform is particularly suited for monitoring Salmonella in poultry and swine operations, where rapid fecal or carcass rinse testing is critical for compliance with food safety regulations.

The clinical context of bovine mastitis-the most costly disease in dairy production-has driven innovation in electrochemical sensing for both pathogens and antimicrobial residues. Staphylococcus aureus and Escherichia coli are predominant causative agents, and their rapid identification is essential for targeted antibiotic therapy. A bioreceptor-free Prussian blue electrochemical sensor, which detects bacterial-driven reduction of Prussian blue to Prussian white via extracellular electron transfer, demonstrated reliable detection of E. coli and S. aureus in blood culture within 3 hours, with a dynamic range spanning 10^2 to 10^8 CFU/mL [23]. While this sensor was developed for human bloodstream infections, its principle is directly translatable to bovine blood or milk samples. The ability to detect viable bacteria without the need for specific antibodies or aptamers reduces cost and complexity, making it attractive for on-farm use. Furthermore, the detection of tetracycline residues in milk-a major concern for dairy farmers facing bulk tank contamination-has been addressed by emerging electrochemical sensors that exploit the redox activity of these antibiotics or their interaction with DNA aptamers [29]. Real-time monitoring of tetracycline levels in milk lines could prevent costly tank rejections and reduce the selective pressure for antimicrobial resistance (AMR) in the dairy environment.

The specter of transboundary animal diseases, such as African Swine Fever Virus (ASFV) and Foot-and-Mouth Disease Virus (FMDV), necessitates surveillance tools that can be deployed at points of entry and in the field. While many electrochemical sensors have focused on bacterial targets, the principles of nucleic acid amplification coupled with electrochemical readout are equally applicable to viral genomes. A sequence-specific electrochemical genosensor for Salmonella, which combined helicase-dependent amplification (HDA) with a sandwich hybridization assay on indium-tin oxide electrodes, achieved single-copy detection-a sensitivity that rivals or surpasses real-time PCR [55]. This approach, when adapted to viral RNA or DNA targets, could provide a rapid, instrument-free alternative for diagnosing ASFV or FMDV in suspect animals. The integration of isothermal amplification (e.g., RPA or LAMP) with CRISPR/Cas12a or Cas13 cleavage, coupled with electrochemical transduction, is a particularly promising avenue for field-deployable viral diagnostics [43]. For example, a field-deployable RPA-CRISPR/Cas12a platform for airborne foodborne bacteria achieved LODs as low as 4.5 CFU/mL for Salmonella enteritidis within 45 minutes [41]; analogous systems targeting Classical Swine Fever Virus or Peste des Petits Ruminants Virus could revolutionize outbreak response in swine and small ruminant populations.

Companion Animal Diagnostics: Wound Care, Respiratory Panels, and Sepsis Monitoring

In companion animal medicine, the clinical presentation of infection is often subtle, and the window for effective intervention is narrow. Electrochemical sensors offer the potential for continuous, real-time monitoring of wound infections, respiratory pathogens, and systemic sepsis, directly in the veterinary clinic or even at home. Chronic wounds in dogs and cats-often secondary to trauma, surgery, or underlying metabolic disease-are frequently colonized by polymicrobial biofilms dominated by Pseudomonas aeruginosa, Staphylococcus aureus, and Proteus mirabilis. The electrochemical detection of phenazine metabolites, particularly pyocyanin (PYO), has emerged as a specific and sensitive strategy for identifying P. aeruginosa infection. Transparent carbon ultramicroelectrode arrays (T-CUAs) have been used to monitor PYO production in real-time over 48 hours, revealing that PYO concentrations peak at approximately 21 hours of growth and then plateau, with maximum concentrations of 190 +/- 5 microM in tryptic soy broth [20]. This temporal dynamic is clinically relevant, as it suggests that sensor readings taken during the logarithmic growth phase could provide early warning of infection before clinical signs are apparent. Flexible laser-induced graphene (LIG) sensors functionalized with molybdenum polysulfide (MoSx) have demonstrated a LOD of 0.19 microM for PYO and 1.2 microM for phenazine-1-carboxylic acid (PCA) in wound-simulating medium, with the ability to monitor biofilms over several days [13]. These sensors can be integrated into wound dressings, providing a non-invasive, continuous readout of pathogen activity. Furthermore, the same LIG platform, when functionalized with gold nanostructures, enabled real-time monitoring of P. aeruginosa biofilm response to gentamicin, confirming that biofilm-embedded cells exhibit at least 100-fold greater tolerance compared to planktonic cells [12]. This capability is transformative for veterinary wound management, as it allows clinicians to assess antibiotic efficacy in situ and tailor therapy accordingly.

The detection of Proteus mirabilis-a common cause of complicated urinary tract infections and wound infections in dogs and cats-has been achieved using disposable electrochemical impedance spectroscopy (EIS) sensors. In a simulated wound fluid model, a significant decrease in charge transfer resistance was observed within 1 hour of inoculation at a concentration of 7.4 x 10^6 CFU/mL, with the impedance signal correlating with bacterial metabolism and growth [18, 51]. The ability to detect P. mirabilis in a complex, protein-rich matrix like wound fluid underscores the robustness of EIS-based approaches for point-of-care use. Similarly, a multiplexed electrochemical platform for detecting Salmonella Typhimurium and E. coli O157 in potable water achieved LODs of 0.8 and 0.9 CFU/mL, respectively, within 5 minutes using a non-faradaic impedance approach [22]. While developed for water safety, this platform could be adapted for testing drinking water sources in kennels or catteries, where E. coli and Salmonella outbreaks are common.

Respiratory infections in companion animals, particularly those caused by Canine Influenza A Virus, Feline Herpesvirus 1, and Bordetella bronchiseptica, require rapid differentiation to guide antiviral or antibiotic therapy. Electrochemical biosensors integrated with microfluidic sample processing offer a pathway to multiplexed respiratory panels. A portable real-time PCR system for airborne bacteria, which detected Staphylococcus aureus, Staphylococcus epidermidis, Bacillus cereus, and Micrococcus luteus with LODs ranging from 6 to 60 CFU/mL within 2 hours, demonstrates the feasibility of on-site nucleic acid detection [52]. While this system uses thermal cycling, the integration of isothermal amplification with electrochemical readout could yield a simpler, faster device suitable for veterinary clinics. The development of a smartphone-assisted electrochemical sensor for chloramphenicol detection-an antibiotic still used in some veterinary contexts despite human safety concerns-achieved a LOD of 46 nM with excellent stability and reproducibility [49]. This platform, which integrates with a pocket-sized potentiostat and a user-friendly app, exemplifies the convergence of sensor technology with mobile health (mHealth) platforms, enabling veterinarians to perform antibiotic residue testing in the field.

Antimicrobial Resistance Surveillance and Stewardship

The global crisis of antimicrobial resistance (AMR) is amplified in veterinary medicine by the widespread use of antibiotics in livestock and the close contact between companion animals and humans. Electrochemical sensors are uniquely positioned to support AMR surveillance and stewardship by providing rapid phenotypic or genotypic resistance profiling. The detection of beta-lactamase-an enzyme conferring resistance to beta-lactam antibiotics-using an electrochemical immunostrip sensor with a 3D hydrogel-paper scaffold achieved a LOD of 0.146 mU/mL and could differentiate beta-lactamase-producing Staphylococcus aureus (including MRSA) from non-producing isolates with ~100% specificity [21]. This sensor provided results within 1 hour post-culture and enabled real-time monitoring of antibiotic therapy efficacy within 4 hours. In a livestock context, such a sensor could be used to screen nasal swabs from pigs for MRSA, a major zoonotic concern. Similarly, electrochemical sensors for antibiotic susceptibility testing (AST) have been classified into four categories based on their detection strategy: genotypic detection of resistance genes, impedance-based monitoring of bacterial lysis, current-based detection of membrane damage, and redox-based monitoring of metabolic activity [47]. For example, the detection of Salmonella at the single-copy level using an electrochemical genosensor [55] could be adapted to detect resistance genes such as blaCTX-M or mcr-1 in livestock fecal samples, providing early warning of emerging resistance trends.

The integration of predictive analytics with IoT-enabled farm sensors represents a paradigm shift in AMR management. A proposed framework combining Long Short-Term Memory (LSTM) networks for trend forecasting and Random Forest classification for hotspot detection achieved a 0.7% mean absolute error in 14-day resistance forecasts and 85% classification accuracy for high-risk events in pilot deployments on Midwestern hog farms [14]. This system, which integrates veterinary prescription records, environmental sampling, and real-time sensor data, led to a 22% reduction in antimicrobial use and an 18% decrease in clinical resistance incidents over six months. While this framework currently relies on a combination of sensor types, the incorporation of electrochemical pathogen sensors as a direct input for resistance gene detection would further enhance its predictive power. The economic impact of such systems is substantial, with projected savings of $75 million annually in livestock antimicrobial expenditures and $200 million in reduced human healthcare costs from mitigated resistance [14].

Environmental and Food Chain Monitoring: The One Health Interface

Electrochemical sensors are not confined to direct animal sampling; they are increasingly deployed at the interface of animal health, environmental quality, and food safety-a core tenet of the One Health approach. The monitoring of water sources used for livestock drinking or aquaculture is critical for preventing waterborne outbreaks. A microfluidic system employing RNA-cleaving DNAzymes (RCDs) for continuous, real-time detection of Legionella pneumophila in cooling tower water achieved a LOD of 1.9 x 10^3 CFU/mL, meeting regulatory requirements [24]. While Legionella is primarily a human pathogen, the same RCD-based platform could be adapted for veterinary-relevant waterborne pathogens such as Leptospira spp. or Piscirickettsia salmonis. The deployment of microfabricated electrochemical sensor arrays in river systems for biofilm detection, using EIS to track constant phase element (CPE) magnitude over 600 hours, demonstrated the feasibility of autonomous, long-term environmental monitoring [35]. Such sentinel systems could provide early warning of fecal contamination events from livestock runoff, enabling rapid intervention to protect both animal and human health.

In the food chain, electrochemical sensors are being integrated into smart packaging to provide real-time spoilage and pathogen detection. Flexible biosensors based on laser-induced graphene or aerosol-jet-printed graphene have been developed for detecting glucose, lactate, and pathogens in saliva and sweat [56], and these same platforms can be adapted for food contact surfaces. The detection of histamine and putrescine in fish, deoxynivalenol in cereals, and Salmonella in poultry products using nanomaterial-modified electrodes has been extensively reviewed [36, 37]. The integration of these sensors with IoT and blockchain technologies, as proposed in a comprehensive review of AI, IoT, and blockchain in microbial analysis [1], could create a tamper-proof record of pathogen detection events from farm to fork. This is particularly relevant for high-risk commodities such as raw milk, where electrochemical sensors for tetracyclines [29] or beta-lactams could be integrated into bulk tank monitoring systems, automatically triggering alerts and blockchain-based traceability updates.

Species-Specific Challenges and Matrix Interference

The clinical deployment of electrochemical sensors in veterinary settings is not without significant challenges. The biological matrices encountered-milk, blood, wound exudate, feces, and saliva-are far more complex and variable than the buffer solutions used in initial sensor characterization. Milk, for example, contains high concentrations of proteins (casein, lactoglobulin), fats, and calcium ions that can foul electrode surfaces and interfere with biorecognition events. A review of electrochemical sensors for tetracycline detection in milk highlighted that while many sensors achieve excellent LODs in buffer, performance often degrades in real milk samples due to matrix effects [29]. Strategies to mitigate this include the use of molecularly imprinted polymers (MIPs) that provide selective binding cavities resistant to fouling [46], or the incorporation of microfluidic sample pre-treatment modules that filter or dilute the matrix prior to analysis [17]. Similarly, blood samples from septic animals contain high levels of proteins, cells, and clotting factors that can impede electron transfer. The Prussian blue sensor for blood culture [23] addressed this by relying on bacterial metabolism to reduce the redox mediator, a process that is less susceptible to protein fouling than antibody-based capture.

Species-specific differences in pathogen biology also pose challenges. For example, the phenazine profile of P. aeruginosa isolates from canine otitis may differ from that of human clinical isolates, potentially affecting sensor calibration. The development of sensors that target conserved metabolic markers, such as the redox-active phenazines common to all P. aeruginosa strains [13, 20], mitigates this issue. For viral pathogens, the high mutation rates of RNA viruses such as Equine Influenza A Virus or Porcine Reproductive and Respiratory Syndrome Virus necessitate careful selection of conserved genomic regions for nucleic acid-based sensors. The use of CRISPR/Cas12a or Cas13 systems, which can tolerate some sequence mismatches in the guide RNA, offers a degree of robustness against viral drift [43]. Furthermore, the integration of artificial intelligence (AI) for signal processing and pattern recognition is emerging as a powerful tool to overcome matrix interference and sensor drift. Machine learning algorithms can be trained to distinguish specific pathogen signals from background noise in complex matrices, improving both sensitivity and specificity [27, 38]. For instance, AI-enhanced electrochemical sensors for E. coli, Salmonella, and S. aureus have demonstrated improved multiplexed detection and adaptability to complex food environments [27].

Regulatory and Practical Deployment Considerations

The path from laboratory validation to clinical adoption in veterinary practice is fraught with regulatory and practical hurdles. In the United States, the USDA's Center for Veterinary Biologics (CVB) regulates diagnostic test kits for animal diseases, while the FDA's Center for Veterinary Medicine (CVM) oversees devices used in food-producing animals. Sensors intended for use in livestock must demonstrate not only analytical sensitivity and specificity but also robustness under field conditions-temperature extremes, humidity, dust, and operator variability. The World Organisation for Animal Health (WOAH, formerly OIE) provides guidelines for the validation of diagnostic assays, which include requirements for repeatability, reproducibility, and diagnostic sensitivity/specificity in target populations. Many of the electrochemical sensors reviewed here have been validated only in spiked buffer or limited food matrices; large-scale field trials in livestock operations or veterinary clinics are conspicuously absent. The development of a portable multi-sensor device for foodborne pathogen detection [54] and the smartphone-assisted chloramphenicol sensor [49] represent steps toward user-friendly, field-ready devices, but their deployment in real-world veterinary settings remains to be demonstrated.

Power supply and data management are additional practical concerns. In remote livestock operations, access to reliable electricity may be limited. Self-powered sensors, such as those based on biofuel cells that harvest energy from glucose or lactate in the sample, are an active area of research [53]. The integration of wireless data transmission via LoRa or Wi-Fi, as demonstrated in the river biofilm monitoring system [35], enables remote data collection and cloud-based analysis, facilitating centralized surveillance. The use of blockchain for secure, transparent traceability of sensor data [1] could address concerns about data integrity in regulatory contexts. Finally, the cost of sensor production must be low enough to justify single-use or limited-reuse formats in veterinary practice. Screen-printed electrodes, which are mass-produced at low cost, are a promising substrate, and their modification with

Integration with IoT, AI, and Blockchain for Real-Time Surveillance

The transformation of electrochemical biosensors from benchtop analytical tools into field-deployable, autonomous surveillance instruments represents a paradigm shift in veterinary clinical pathology. This evolution is fundamentally predicated upon the synergistic convergence of three distinct yet interdependent technological domains: the Internet of Things (IoT), artificial intelligence (AI), and blockchain. Within the context of real-time veterinary pathogen monitoring, this triad forms the operational backbone of a decentralized, intelligent, and verifiable surveillance ecosystem. The integration is not merely additive; it is multiplicative, where the strengths of each technology compensate for the limitations of the others, creating a system that is greater than the sum of its parts.

IoT-Enabled Distributed Sensing Networks and Edge Computing

The foundational layer of any real-time surveillance architecture is the physical sensor network. Electrochemical sensors, by their very nature, are exquisitely suited for IoT integration due to their low power consumption, miniaturization potential, and direct electronic signal output. The deployment of these sensors within IoT frameworks enables a shift from discrete, laboratory-based testing to continuous, in situ monitoring across vast geographic scales [1, 32]. In practical veterinary applications, this means embedding sensor arrays within livestock housing, aquaculture facilities, poultry barns, and even mobile diagnostic units. Each sensor node, equipped with a microcontroller (e.g., ESP32) and wireless communication modules (Wi-Fi, LoRa, Bluetooth Low Energy), becomes a data acquisition point capable of transmitting electrochemical impedance spectroscopy (EIS) data, amperometric readings, or potentiometric signals to a centralized or distributed processing hub [35, 54].

A critical advancement in this domain is the implementation of edge computing. Transmitting raw, high-frequency electrochemical data from hundreds or thousands of sensors to a cloud server is bandwidth-prohibitive and introduces unacceptable latency for time-sensitive pathogen detection. Edge computing addresses this by performing preliminary signal processing, feature extraction, and anomaly detection directly on the sensor node or a nearby gateway [14]. For instance, in monitoring for Avian Influenza Virus in poultry houses, an edge-processor can analyze cyclic voltammetry data for characteristic redox peaks associated with viral neuraminidase activity, triggering an alert only when a threshold is crossed, rather than streaming continuous waveforms. Similarly, in aquaculture settings, sensorized microfluidic devices can be deployed to monitor for Infectious Salmon Anemia Virus or White Spot Syndrome Virus, with on-board algorithms processing impedance changes from DNAzyme-based assays [24] or CRISPR-mediated cleavage events [2, 41, 43].

The practical realization of such networks has been demonstrated through smart silo grain storage systems, where IoT sensor networks monitor temperature, humidity, and CO2 levels to predict fungal growth and mycotoxin contamination [25]. Translating this to veterinary contexts, similar architectures can monitor the microenvironment of wound dressings using flexible electrochemical sensors for Pseudomonas aeruginosa phenazine metabolites [12, 13, 20, 26] or for detecting Canine Parvovirus in kennel environments. The use of LoRa radio technology, capable of transmitting data over distances exceeding 20 kilometers in rural areas, is particularly impactful for monitoring extensive grazing operations or remote aquaculture sites where cellular coverage is absent [35]. This creates a true "pasture-to-plate" continuous monitoring paradigm, fundamentally altering the temporal resolution of veterinary epidemiology.

AI-Driven Predictive Analytics and Intelligent Signal Deconvolution

While IoT provides the data pipeline, AI provides the intelligence necessary to interpret it. The complexity of electrochemical signals in biological matrices-replete with noise, drift, and overlapping analyte responses-renders simple threshold-based algorithms inadequate for robust pathogen identification. Machine learning (ML) and deep learning (DL) algorithms address this by learning complex, non-linear patterns from high-dimensional sensor data [8, 27, 38]. This capability is operationalized across several critical levels within the surveillance framework.

At the signal processing level, AI algorithms are deployed for denoising, baseline correction, and feature extraction. Convolutional neural networks (CNNs) can be trained on raw voltammograms or impedance spectra to identify subtle signatures indicative of specific pathogen-derived metabolites or nucleic acid amplification products [27]. This is paramount for multiplexed detection, where a single electrochemical sensor must differentiate between multiple targets simultaneously. For example, a smartphone-assisted magnetic MOF-RPA-CRISPR platform [2] can generate complex optical or electrochemical signals that require AI-driven deconvolution to distinguish between Salmonella Typhimurium, Staphylococcus aureus, and Listeria monocytogenes. Similarly, in the detection of antibiotic residues like tetracyclines in milk [29] or chloramphenicol [49], AI models can disentangle overlapping redox peaks from multiple antibiotic families.

At the predictive analytics level, AI models, particularly Long Short-Term Memory (LSTM) networks and Random Forest classifiers, are employed for trend forecasting and risk stratification [14]. This moves the surveillance system from a reactive "detect and respond" model to a proactive "predict and prevent" paradigm. Consider the challenge of antimicrobial resistance (AMR) in livestock. A predictive framework integrating IoT-enabled farm sensors (tracking antibiotic usage, animal temperature, and environmental samples) with LSTM networks can forecast the probability of a resistance outbreak up to 14 days in advance with high accuracy [14]. This allows veterinarians to implement targeted stewardship interventions before clinical disease manifests. The same approach can be applied to predict the onset of Porcine Reproductive and Respiratory Syndrome Virus outbreaks in swine herds or Newcastle Disease Virus epizootics in poultry, using time-series data from embedded electrochemical sensors monitoring viral RNA or host inflammatory biomarkers.

Furthermore, AI is revolutionizing the design of the sensing elements themselves. The "Design-Build-Test-Learn" (DBTL) cycle for synthetic biology biosensors (SBBs) is being accelerated by AI-driven prediction of aptamer structures, guide RNA sequences for CRISPR systems, and optimal amplifier configurations [8]. This is particularly relevant for developing sensors against emerging or genetically diverse pathogens like African Swine Fever Virus or Foot-and-Mouth Disease Virus, where traditional recognition elements may fail. AI can predict binding affinities and cross-reactivity in silico, significantly reducing the time and cost of sensor development [9]. The integration of explainable AI (XAI) is also critical for veterinary clinical acceptance, as pathologists require mechanistic understanding of why an algorithm flagged a sample as positive, not merely a probabilistic output [27, 38].

Blockchain for Immutable Data Provenance and Trustworthy Surveillance

The final pillar of this integrated architecture is blockchain technology, which addresses the critical challenges of data integrity, traceability, and trust in multi-stakeholder surveillance systems. In a globalized veterinary landscape, pathogen monitoring data flows between farms, veterinary clinics, diagnostic laboratories, regulatory bodies (e.g., USDA, WOAH), and food supply chain actors. Without a robust mechanism for ensuring data immutability, the entire surveillance framework is vulnerable to tampering, fraud, and disputes [1, 38].

Blockchain provides a decentralized, distributed ledger where each data point-from the raw electrochemical sensor reading at the farm to the final diagnostic confirmation at the reference lab-is recorded as a cryptographically sealed "block." These blocks are chained together in a chronological and immutable sequence, making retroactive alteration computationally infeasible [1]. For veterinary pathogen surveillance, this has profound implications. Consider an outbreak of Classical Swine Fever Virus. A blockchain-secured system can provide a verifiable, timestamped record of every diagnostic test performed, every movement of animals, and every intervention applied. This creates an indisputable audit trail that is invaluable for epidemiological investigations, compensation claims, and trade certification.

The integration of smart contracts-self-executing contracts with the terms of the agreement directly written into code-automates critical responses based on sensor data. For example, a smart contract could be programmed to automatically trigger a quarantine order, notify veterinary authorities, and halt the movement of animals from a facility the moment an electrochemical sensor detects a threshold level of Highly Pathogenic Avian Influenza Virus RNA. This eliminates delays inherent in manual reporting and decision-making, dramatically accelerating outbreak containment. In the food supply chain, blockchain can create a transparent "farm-to-fork" record of pathogen testing, allowing consumers and retailers to verify the safety of meat, milk, or eggs with cryptographic certainty [36]. This is particularly salient for preventing economically motivated adulteration and food fraud, where negative test results could be fabricated.

The convergence of blockchain with AI and IoT creates a powerful feedback loop. AI algorithms analyzing sensor data can autonomously generate "suspicion scores" that are recorded on the blockchain, triggering smart contracts for further investigation. The immutability of the blockchain also provides a reliable dataset for training future AI models, creating a virtuous cycle of continuous improvement [8, 38]. Challenges remain, including the computational overhead of proof-of-work consensus mechanisms on low-power IoT devices, and the need for standardization of data formats across the veterinary ecosystem. However, the emergence of lightweight blockchain protocols (e.g., directed acyclic graphs) and permissioned ledger systems are making this integration increasingly feasible for field deployment.

A Unified Architecture for One Health Surveillance

When synthesized, the IoT-AI-Blockchain triad forms a comprehensive "One Health Observatory" [42] for real-time pathogen monitoring. This architecture operates across multiple tiers: the sensor tier (electrochemical biosensors on IoT nodes), the edge tier (local AI for signal processing and initial anomaly detection), the cloud tier (advanced AI models for predictive analytics and cross-farm pattern recognition), and the trust tier (blockchain for immutable data provenance). This layered approach addresses the core challenges of data integration, collaborative monitoring, and cross-domain communication that have historically plagued veterinary surveillance systems [42].

The practical impact of such an integrated system is transformative. In a large-scale swine operation, for instance, electrochemical sweat sensors on animals [33] could continuously monitor for metabolites indicative of stress or early infection with Swine Influenza A Virus. This data is processed at the edge to filter noise, then transmitted via LoRa to a cloud-based AI system that predicts the trajectory of the outbreak. The predictions are recorded on a permissioned blockchain accessible to the farm's veterinarian, the regional animal health authority, and downstream processors. If the AI model predicts a high risk of within-herd transmission, a smart contract automatically adjusts ventilation and feeding protocols and schedules targeted diagnostic testing using a secondary electrochemical panel for viral RNA [55].

Similarly, in aquaculture, IoT-enabled water monitoring stations with electrochemical sensors for Tilapia Lake Virus or Nervous Necrosis Virus can communicate with a centralized dashboard. AI algorithms analyze trends in water chemistry (pH, temperature, dissolved oxygen) alongside pathogen detection events to predict disease outbreaks, while blockchain ensures that the certification of pathogen-free status for export shipments is verifiable and tamper-proof. This integration represents the culmination of decades of research in electrochemical sensing, computational biology, and distributed systems, offering a robust, scalable, and trustworthy solution for safeguarding animal health and public health in the 21st century.

Challenges, Calibration, and Future Directions for Field Deployment

The translation of electrochemical sensor platforms from controlled laboratory environments to the chaotic, heterogeneous, and resource-constrained realities of veterinary field deployment represents one of the most formidable obstacles in the translational pipeline. While the preceding sections have catalogued remarkable advances in sensitivity, specificity, and multiplexing capacity, the practical implementation of these technologies for real-time pathogen monitoring in livestock operations, aquaculture facilities, companion animal clinics, and wildlife surveillance networks confronts a constellation of interconnected challenges that span biofouling, matrix interference, calibration drift, power autonomy, data integrity, and regulatory validation. Failure to systematically address these barriers will consign even the most elegant sensor designs to the purgatory of proof-of-concept publications, never achieving the operational maturity required for routine veterinary clinical decision-making. This section provides an exhaustive, clinically grounded analysis of these deployment challenges, critically evaluates existing and emerging calibration strategies, and outlines a roadmap for future innovation that is both technologically ambitious and pragmatically achievable.

The Irreducible Complexity of Veterinary Sample Matrices

Perhaps the most pervasive and underestimated challenge in field deployment is the extraordinary compositional complexity of veterinary biological samples. Unlike idealized buffer solutions or even standardized human clinical specimens, veterinary matrices-whole blood, serum, plasma, milk, urine, saliva, nasal swab eluates, feces, tissue homogenates, and aquaculture water-present a kaleidoscopic array of interfering substances that can profoundly compromise sensor performance. Milk, for instance, is a complex oil-in-water emulsion containing approximately 3.5% protein (primarily casein micelles and whey proteins), 3.5-5% fat globules, lactose, minerals, somatic cells, and variable concentrations of endogenous metabolites and drug residues [29]. Electrochemical sensors deployed for direct milk analysis, such as those targeting tetracycline residues in bulk tank milk, must contend with severe electrode fouling from casein adsorption, lipid deposition that impedes electron transfer, and heterogeneous matrix effects that alter the electrochemical double-layer capacitance and charge transfer resistance [29, 36]. Similarly, whole blood and serum samples are replete with albumin, immunoglobulins, fibrinogen, and cellular elements that rapidly adsorb onto electrode surfaces, forming passivating protein layers that attenuate signal intensity and induce unpredictable baseline drift [23, 39]. The electrochemical detection of bloodstream pathogens, including Bovine Viral Diarrhea Virus or Porcine Reproductive and Respiratory Syndrome Virus, using bioreceptor-free approaches that rely on bacterial extracellular electron transfer must navigate the confounding influence of endogenous redox-active species such as uric acid, ascorbic acid, and bilirubin, which generate non-specific faradaic currents [23, 31]. For fecal samples, the challenge is compounded by the presence of bile salts, undigested food debris, complex microbial communities, and variable pH that can denature immobilized biorecognition elements and disrupt hybridization kinetics in DNA-based sensors [48].

The implications for veterinary pathogen monitoring are profound. A sensor that demonstrates a limit of detection of 10 CFU/mL in phosphate-buffered saline may exhibit a 100- to 1000-fold degradation in performance when challenged with undiluted rumen fluid, avian fecal homogenate, or salmonid mucus. This "matrix penalty" is not merely a quantitative inconvenience; it fundamentally undermines the clinical utility of the sensor for early detection applications where pathogen loads may be at or near the analytical threshold. For example, the detection of Avian Influenza Virus in cloacal swabs or Infectious Salmon Anemia Virus in gill mucus requires sensors that can function reliably in matrices rich in mucopolysaccharides, proteolytic enzymes, and microbial debris [41, 52]. Addressing these matrix effects demands a multi-pronged strategy: (i) the incorporation of sample pre-treatment modules, such as microfluidic filtration, magnetic bead-based clean-up, or dielectrophoretic separation, that can selectively enrich target pathogens while excluding interferents [2, 15, 40]; (ii) the development of anti-fouling electrode coatings, including zwitterionic polymer brushes, polyethylene glycol layers, or hydrogel scaffolds that resist protein adsorption [21, 33]; and (iii) the implementation of ratiometric or internal standard-based measurement schemes that can normalize for matrix-induced signal suppression [36, 38]. The work by Choi et al. [40] exemplifying engineered phage tail spike protein-based magnetic separation (T-MS) for viable Salmonella detection demonstrates the power of integrated sample preparation, achieving 80-90% capture efficiency in complex food matrices including milk, lettuce, and pork. Similarly, the magnetic nanobead chain-based separation approach reported by Jiang et al. [15] for Salmonella detection in microfluidic chips illustrates how physical enrichment can be coupled with impedimetric readout to achieve detection limits of 50 CFU/mL in buffer, though validation in authentic veterinary matrices remains limited.

Biofouling and Biofilm Formation: The Inevitable Degradation of Sensor Interfaces

Beyond the acute matrix effects encountered during individual measurements, field-deployed sensors face the insidious and cumulative challenge of biofouling-the progressive accumulation of biological material on sensor surfaces over time. For continuous or semi-continuous monitoring applications, such as in-line milk quality sensors in dairy parlors, real-time water quality monitors in aquaculture recirculating systems, or implantable sensors for postoperative infection surveillance, biofouling represents an existential threat to sensor longevity and data reliability [33, 35, 57]. The initial phase of biofouling involves the rapid adsorption of proteins and polysaccharides within minutes of exposure, forming a conditioning film that alters the surface energy and electrochemical properties of the electrode. This is rapidly followed by the adhesion of planktonic bacteria, which, given sufficient nutrient availability and quorum sensing signaling, differentiate into matrix-encased biofilms that can completely occlude the sensing surface [12, 13, 57]. The electrochemical consequences are manifold: increased double-layer capacitance from the dielectric properties of the biofilm matrix, elevated charge transfer resistance due to hindered diffusion of redox probes, and the generation of spurious signals from the metabolic activity of the biofilm itself [18, 35, 51]. The work by Neubauer et al. [35] on microfabricated electrochemical sensor arrays deployed in the Clark Fork River for two months provides compelling field evidence of biofilm-induced signal evolution. The constant phase element (CPE) magnitude derived from electrochemical impedance spectroscopy (EIS) fitting increased progressively over 600 hours, saturating as a complete biofilm layer formed, demonstrating both the inevitability and the detectability of biofouling in real-world aquatic environments.

For veterinary applications, the implications are stark. An electrochemical sensor deployed for continuous monitoring of White Spot Syndrome Virus in shrimp pond water or Koi Herpesvirus in ornamental fish tanks would likely experience severe biofouling within days to weeks, depending on water temperature, nutrient load, and microbial community composition. Similarly, sensors integrated into wound dressings for monitoring Pseudomonas aeruginosa infection in equine or canine patients must contend with a wound environment rich in serum proteins, leukocytes, and necrotic tissue debris that rapidly degrades sensor performance [26, 33, 57]. Strategies to mitigate biofouling include the application of fouling-resistant polymer coatings, such as poly(ethylene glycol) (PEG) brushes, zwitterionic sulfobetaine methacrylate polymers, or slippery liquid-infused porous surfaces [33]; the integration of antimicrobial or antibiofilm agents, including silver nanoparticles, antimicrobial peptides, or nitric oxide-releasing materials [26, 33]; and the use of periodic electrochemical cleaning protocols, such as pulsed potential waveforms or high-frequency AC electroosmotic flows, that can disrupt adherent bacteria without damaging the sensor [18, 51]. The work by Zhou et al. [12, 13] on laser-induced graphene (LIG) sensors functionalized with molybdenum polysulfide or gold nanostructures for real-time monitoring of P. aeruginosa phenazines demonstrated that careful material selection can minimize bactericidal effects that would otherwise confound continuous monitoring. The "Flipped" configuration in which the sensor was not in direct contact with the biofilm was particularly instructive, showing that physical separation can protect the sensor while still allowing detection of diffusible metabolites [13]. Future sensor designs for veterinary field deployment should incorporate redundant sensing channels, where one channel serves as a biofouling monitor that can be used to algorithmically correct signals from the primary analytical channel, or microfluidic cleaning modules that periodically flush the sensing surface with sterile buffer or enzymatic cleaning solutions.

Calibration Drift and the Quest for Quantitative Stability

Calibration drift-the gradual, often unpredictable change in the relationship between sensor signal and analyte concentration over time-is a persistent and pernicious challenge that undermines the quantitative reliability of electrochemical sensors in field settings. Unlike benchtop instruments that can be recalibrated with standards before each use, field-deployed sensors may operate for hours, days, or weeks without recalibration, accumulating errors from electrode fouling, degradation of biorecognition elements, temperature fluctuations, and changes in ionic strength or pH of the sample matrix [1, 19, 25]. For aptamer-based electrochemical sensors (E-AB sensors), which rely on target-induced conformational changes in surface-immobilized aptamers, signal drift can arise from aptamer unfolding, nuclease degradation, or irreversible binding of matrix components that impede the conformational switch [19]. Chung et al. [19] systematically characterized the compatibility of E-AB sensors with standard sterilization and high-level disinfection techniques, finding that while many common disinfectants lead to significant sensor degradation, treatment with ortho-phthalaldehyde (CIDEX OPA) achieved effective disinfection without detectable loss in sensor performance. This work underscores the critical need for rigorous validation of sensor stability under field-relevant conditions, including exposure to disinfectants, temperature extremes, and prolonged contact with biological matrices.

For impedance-based sensors, drift in the baseline impedance can result from changes in electrode surface area due to protein adsorption, variations in solution conductivity from evaporation or sample dilution, and temperature-dependent changes in electrolyte viscosity and ion mobility [18, 35, 51]. The normalization approach employed by Hannah et al. [18, 51] for the detection of Proteus mirabilis in simulated wound fluid, where impedance values at each time point were normalized to the initial impedance, represents a pragmatic strategy for mitigating drift by emphasizing relative changes over absolute measurements. However, such normalization assumes that drift affects the reference and measurement channels equivalently, an assumption that may not hold in heterogeneous biofilms or spatially variable matrices. A more robust approach involves the incorporation of internal calibration standards, such as ferrocene or Prussian blue redox probes that produce a concentration-independent reference signal, enabling ratiometric correction of drift [23, 36]. The Prussian blue-based bioreceptor-free sensor reported by Ramasamy et al. [23] exploited the conversion of Prussian blue to Prussian white by bacterial extracellular electron transfer, with the magnitude of this conversion serving as a proxy for bacterial metabolic activity. While this approach avoids the stability issues associated with bioreceptors, it still requires careful calibration against reference standards to account for day-to-day variations in electrode fabrication and measurement conditions.

The emerging integration of machine learning (ML) and artificial intelligence (AI) into sensor calibration represents a paradigm shift from static, pre-deployment calibration to dynamic, adaptive calibration that learns and corrects for drift in real time [1, 8, 27]. AI-enhanced electrochemical sensing systems can be trained on large datasets of sensor responses across diverse environmental conditions, learning the patterns of drift associated with specific fouling events, temperature cycles, or matrix compositions [27]. This AI-driven calibration can then be deployed as an on-board correction algorithm that processes raw sensor signals and outputs drift-compensated analyte concentrations without requiring frequent manual recalibration. Zhao et al. [27] provide a comprehensive review of AI integration in electrochemical biosensing for food safety, highlighting how deep learning models can extract multi-component signals from complex impedance spectra, separate target-specific responses from matrix-induced artifacts, and predict sensor degradation trajectories. The predictive analytics framework proposed by Akinyemi et al. [14] for antimicrobial resistance surveillance in swine production systems, integrating IoT-enabled farm sensors with LSTM networks for trend forecasting, demonstrates the power of combining real-time sensor data with machine learning for proactive decision-making. However, the "small-data dilemma" remains a significant barrier for veterinary applications, where the availability of large, well-annotated training datasets is limited compared to human clinical or food safety domains [8]. Collaborative data-sharing initiatives, federated learning approaches that preserve data privacy, and the development of pre-trained models that can be fine-tuned for specific veterinary use cases will be essential for overcoming this limitation.

Power Autonomy, Data Connectivity, and the Internet of Veterinary Things

The transition from laboratory instruments tethered to mains power and wired data acquisition to autonomous, wireless field sensors presents formidable engineering challenges that intersect with the unique operational realities of veterinary practice. Livestock operations, particularly extensive grazing systems, feedlots, and pasture-based dairies, often lack reliable electrical infrastructure, and the logistical burden of battery replacement for hundreds of distributed sensors is prohibitive [1, 25]. Aquaculture facilities, especially offshore net-pen operations and remote pond-based systems, face similar constraints, with the added challenge of sensor deployment in corrosive saline environments that accelerate battery degradation and connector failure [10, 35]. Power constraints are particularly acute for sensors that require frequent measurement cycles (e.g., every 15-60 minutes for continuous monitoring), wireless data transmission, and on-board signal processing, each of which imposes a non-trivial energy burden [1, 25, 33]. Energy harvesting strategies, including piezoelectric energy harvesters that convert mechanical vibrations from animal movement or water flow, thermoelectric generators that exploit temperature differentials between the sensor and its environment, and biofuel cells that generate electricity from the metabolic activity of the sample itself, represent promising pathways toward self-powered sensor systems [17, 33]. The integration of printed, flexible energy storage devices, such as printed batteries or supercapacitors, with flexible sensors on common substrates like polyimide or paper, could enable fully integrated, disposable sensor systems that eliminate the need for battery replacement [17, 34].

Data transmission and connectivity constitute the second pillar of the Internet of Veterinary Things (IoVT). The selection of wireless communication protocols must balance data rate, range, power consumption, and cost in a manner that is appropriate for the specific deployment context [1, 14]. For sensors deployed in confined indoor environments, such as dairy parlors, poultry houses, or companion animal clinics, Bluetooth Low Energy (BLE) provides a low-power, short-range solution that can interface with a local gateway connected to the cloud [1]. For extensive outdoor deployments, such as feedlot water troughs, pasture watering points, or aquaculture pens, long-range wide-area network (LoRaWAN) technologies enable data transmission over distances of up to 15-20 kilometers in rural areas with minimal power consumption [1, 35]. The Data Acquisition Station (DAQ) described by Neubauer et al. [35] for river biofilm monitoring exemplifies a modular approach, employing Wi-Fi for short-range high-bandwidth data transfer and LoRa for long-range status updates and control commands. However, the limited bandwidth of LoRaWAN (typically a few hundred bits per second) constrains the transmission of raw electrochemical data, necessitating on-device signal processing and feature extraction to reduce data volume. Edge computing-the execution of ML algorithms directly on the sensor node rather than in the cloud-offers a solution by enabling real-time anomaly detection and decision-making while transmitting only processed results [8, 27]. This architectural approach also addresses data security and privacy concerns, as sensitive health data can be processed locally before transmission [1, 14].

Cybersecurity considerations are often overlooked in veterinary sensor development but are increasingly critical as sensors become integrated into farm management systems, supply chain databases, and national disease surveillance networks [1, 14]. The potential for malicious actors to compromise sensor data, inject false contamination signals, or disrupt automated quarantine protocols represents a non-trivial risk that must be addressed through encryption, authentication, and blockchain-based data integrity mechanisms [1]. The convergence of AI, IoT, and blockchain technologies for microbial risk management, as reviewed by Priyadharsshini et al. [1], provides a framework for secure, transparent traceability that could be adapted for veterinary pathogen monitoring. However, the computational overhead of blockchain consensus mechanisms may be incompatible with resource-constrained sensor nodes, necessitating hierarchical architectures where blockchain is implemented at the gateway or cloud level while sensors maintain simpler, encrypted communication channels.

Standardization, Regulatory Validation, and the Path to Commercialization

The absence of standardized performance metrics, validation protocols, and regulatory frameworks for veterinary electrochemical sensors represents perhaps the most significant barrier to widespread field deployment [32, 36, 39]. Unlike human in vitro diagnostics, which are subject to rigorous FDA premarket review, Clinical Laboratory Improvement Amendments (CLIA) requirements, and ISO 15189 accreditation standards, the regulatory landscape for veterinary diagnostics is fragmented and varies substantially across jurisdictions. The World Organisation for Animal Health (WOAH, formerly OIE) has established guidelines for the validation of diagnostic assays for WOAH-listed diseases, but these guidelines were developed primarily for traditional laboratory-based methods (PCR, virus isolation, ELISA) and have not been systematically adapted for point-of-care or continuous monitoring sensors [39]. This regulatory vacuum creates uncertainty for sensor developers, inhibits investment in clinical validation studies, and slows the adoption of novel technologies by veterinary practitioners who require confidence in diagnostic accuracy.

A critical step toward regulatory harmonization is the development of consensus standards for sensor performance characterization that are appropriate for veterinary field deployment. These standards should specify acceptable parameters for sensitivity, specificity, accuracy, precision, linearity, limit of detection, limit of quantification, and stability under field-relevant conditions, including temperature extremes (-20 degrees C to 50 degrees C), humidity, vibration, and exposure to common veterinary disinfectants [19, 32, 36]. The tiered, application-driven analytical framework proposed by Li et al. [10] for aquaculture pathogen detection, which stratifies immunoassay-based biosensing platforms into quantitative reference systems (ELISA), rapid screening tools (lateral flow immunoassays), and emerging continuous monitoring systems, provides a useful model for establishing performance expectations commensurate with the intended use case. For electrochemical sensors intended for real-time, continuous monitoring, validation studies should include long-term stability assessments (minimum 30 days under simulated use conditions), cross-reactivity panels against a comprehensive panel of relevant pathogens and commensal organisms, and matrix interference studies using authentic veterinary samples from healthy and diseased animals [32, 39].

The path to commercialization also requires scalable manufacturing processes that can

References

1. Priyadharsshini S, Adeyeye S. Advances in the application and use of AI, IoT and blockchain in microbial analysis and safety of food: A comprehensive review . Food Control. 2026. DOI: https://doi.org/10.1016/j.foodcont.2026.112285

2. Lan Z, Yang Z, Peng X, Li X, Zhang T, Chen T, et al.. On-site multiplex detection of foodborne bacteria using a smartphone-assisted magnetic MOF-RPA-CRISPR platform . Sensors and Actuators B: Chemical. 2026. DOI: https://doi.org/10.1016/j.snb.2026.140112

3. Sun B, Chen R, Wang J, Zhang Y, Lei P, Conti G, et al.. Pt-MOF nanozymes: synthesis strategies, catalytic mechanisms, and biosensing applications . Coordination Chemistry Reviews. 2026. DOI: https://doi.org/10.1016/j.ccr.2026.217945

4. Li X, Lin S, Wang X, Liu Y, Ma X, Mao X, et al.. Functional nucleic acids as multifaceted enhancers for next-generation LAMP . TrAC Trends in Analytical Chemistry. 2026. DOI: https://doi.org/10.1016/j.trac.2026.118884

5. Kopar A, Turgut B, Kucuk B, Turalioglu K, Kalin R, Derman M, et al.. A mini review on biosensing of Janus transition metal dichalcogenides: Fundamentals, devices, emerging applications, and future perspectives . Micro and Nanostructures. 2026. DOI: https://doi.org/10.1016/j.micrna.2026.208696

6. Caballos I, Hernandez-Montoto A, Climent E, Gil-Brusola A, Martinez-Manez R, Aznar E. Targeted detection of Mycobacterium tuberculosis MPT64 antigen using an antibody-coated nanoporous anodic alumina biosensor: A novel approach for tuberculosis screening. Talanta. 2026. DOI: https://doi.org/10.1016/j.talanta.2026.129625

7. Ha H, Nguyen L, Nguyen D, Nguyen T, Tran T. Metal-organic framework-derived porous carbons: synthesis, antibiotic adsorption performance, reusability and challenges . Separation and Purification Technology. 2026. DOI: https://doi.org/10.1016/j.seppur.2026.137785

8. Chang K, Sun J, Bao Q, Fu X, Ping J, Yu B, et al.. Engineering synthetic biology sensors with artificial intelligence: From programmable circuits to next-generation biosensing . Biotechnology Advances. 2026. DOI: https://doi.org/10.1016/j.biotechadv.2026.108874

9. Shovey A, Zahraee H, Mahroughi S, Felletti S, Catani M, Cavazzini A, et al.. Aptamer-based enantioselective biosensors: a review of strategies for chiral biomolecule detection . Microchemical Journal. 2026. DOI: https://doi.org/10.1016/j.microc.2026.118335

10. Li W, Xu Z, He Q, Pan J, Zhao Y, Liu W, et al.. Immunoassay-based biosensing for aquaculture pathogen detection: A tiered and application-driven analytical framework . Aquaculture. 2026. DOI: https://doi.org/10.1016/j.aquaculture.2026.744013

11. Tertis M, Canciu A, Tanasa S, Diana O, Bogdan D, Suciu M, et al.. Rapid electrochemical detection of Campylobacter jejuni using a label-free aptasensor based on a hybrid Au NPs/MXene nanocomposite. Electrochimica Acta. 2026. DOI: https://doi.org/10.1016/j.electacta.2026.148683

12. Zhou K, Kammarchedu V, Ebrahimi A. Direct Laser-Functionalized Au-LIG Sensors for Real-time Electrochemical Monitoring of Response of Pseudomonas aeruginosa Biofilms to Antibiotics. ECS Sensors Plus. 2023. DOI: https://doi.org/10.1149/2754-2726/ad08d4

13. Zhou K, Kammarchedu V, Butler D, Khamsi PS, Ebrahimi A. Electrochemical Sensors based on MoSx-functionalized Laser Induced Graphene for Real-time Monitoring of Phenazines produced by Pseudomonas aeruginosa. Advanced Healthcare Materials. 2022. DOI: https://doi.org/10.1002/adhm.202200773

14. Akinyemi I, Iledare A, Oluwatobi AD, Itunu T, Suleiman M, Victoria A, et al.. Predictive Analytics framework for real-time surveillance of Antimicrobial Resistance in Food systems. World Journal of Advanced Research and Reviews. 2025. DOI: https://doi.org/10.30574/wjarr.2025.27.1.2356

15. Jiang F, Wang L, Jin N, Yuan J, Li Y, Lin J. Magnetic nanobead chain-assisted real-time impedance monitoring using PCB interdigitated electrode for Salmonella detection. iScience. 2023. DOI: https://doi.org/10.1016/j.isci.2023.108245

16. Ceccarelli MC, Lefevre M, Marino A, Pignatelli F, Krukiewicz K, Battaglini M, et al.. Real-time monitoring of a 3D blood-brain barrier model maturation and integrity with a sensorized microfluidic device. Lab on a Chip. 2024. DOI: https://doi.org/10.1039/d4lc00633j

17. Sachdev A, Matai I, Kumar D, Kumar V. Innovative 2D Nanomaterials-Based Electrochemical Microfluidic Sensors for Food Safety and Environmental Ecology. ECS Meeting Abstracts. 2024. DOI: https://doi.org/10.1149/ma2024-01492691mtgabs

18. Hannah A, Connolly P, Ward AC. Rapid Detection of Wound Pathogen Proteus mirabilis Using Disposable Electrochemical Sensors. 2021. DOI: https://doi.org/10.11159/icbes21.105

19. Chung J, Sepunaru L, Plaxco K. On the Disinfection of Electrochemical Aptamer-Based Sensors. ECS Sensors Plus. 2022. DOI: https://doi.org/10.1149/2754-2726/ac60b2

20. Simoska O, Sans M, Fitzpatrick MD, Crittenden CM, Eberlin L, Shear J, et al.. Real-Time Electrochemical Detection of Pseudomonas aeruginosa Phenazine Metabolites Using Transparent Carbon Ultramicroelectrode Arrays. ACS Sensors. 2018. DOI: https://doi.org/10.1021/acssensors.8b01152

21. Shukla M, Maiya D, Malaviya R, Raval M, Zala D, Bhatt V, et al.. Electrochemical beta-lactamase immunostrip sensor with 3D hydrogel-paper scaffold for rapid detection and post-antibiotic therapy monitoring in drug-resistant bloodstream infections. Analytica Chimica Acta. 2025. DOI: https://doi.org/10.1016/j.aca.2025.343953

22. Mishra KK, Dhamu VN, Muthukumar S, Prasad S. Quick and Sensitive Two-Plex Electrochemical Platform for Pathogen Detection in Water. Nano Select. 2025. DOI: https://doi.org/10.1002/nano.70017

23. Ramasamy S, Madhu S, Choi J. Rapid and receptor-free Prussian blue electrochemical sensor for the detection of pathogenic bacteria in blood. Bioelectrochemistry. 2025. DOI: https://doi.org/10.1016/j.bioelechem.2025.108902

24. Osman EA, Saxena S, Qian S, L'Heureux-Hache J, Li P, Manek J, et al.. Electrochemical detection of Legionella pneumophila using DNAzymes and under continuous flow in cooling tower water. Biosensors & bioelectronics. 2025. DOI: https://doi.org/10.1016/j.bios.2025.117283

25. Reni DA, Vj R. Design and Development of a Smart Silo Grain Storage Monitoring System. International Scientific Journal of Engineering and Management. 2025. DOI: https://doi.org/10.55041/isjem05282

26. Simoska O, Duay J, Stevenson K. Electrochemical Detection of Multianalyte Biomarkers in Wound Healing Efficacy. ACS Sensors. 2020. DOI: https://doi.org/10.1021/acssensors.0c01697

27. Zhao Y, Sun T, Zhang H, Li W, Lian C, Jiang Y, et al.. AI-Enhanced Electrochemical Sensing Systems: A Paradigm Shift for Intelligent Food Safety Monitoring. Biosensors. 2025. DOI: https://doi.org/10.3390/bios15090565

28. Roudsari ZO, Karami Y, Khoramrooz SS, Rouhi S, Ghasem H, Khatami SH, et al.. Electrochemical and optical biosensors for the detection of E. Coli. Clinica chimica acta; international journal of clinical chemistry. 2024. DOI: https://doi.org/10.1016/j.cca.2024.119984

29. Raykova MR, Corrigan D, Holdsworth M, Henriquez F, Ward AC. Emerging Electrochemical Sensors for Real-Time Detection of Tetracyclines in Milk. Biosensors. 2021. DOI: https://doi.org/10.3390/bios11070232

30. Nguyen TT, Zhou L, Kong J, Luo A, Hao Z, Zhang J. Recent Advances in MXene-Based Screen-Printed Electrochemical Sensors for Point-of-Care Biomarker Detections. Biosensors. 2025. DOI: https://doi.org/10.3390/bios15120804

31. Simoska O, Stevenson K. Electrochemical sensors for rapid diagnosis of pathogens in real time. In Analysis. 2019. DOI: https://doi.org/10.1039/c9an01747j

32. Sakthivel K, Balasubramanian S, Chang-Chien G, Wang S, Ahammad F, Billey W, et al.. Editors' Choice-Review-Advances in Electrochemical Sensors: Improving Food Safety, Quality, and Traceability. ECS Sensors Plus. 2024. DOI: https://doi.org/10.1149/2754-2726/ad5455

33. Zuo L, Liu Y, Zhang J, Wang L, Zhu J. Wearable Electrochemical Biosensors for Monitoring and Management of Chronic Wounds. Biosensors. 2025. DOI: https://doi.org/10.3390/bios15120785

34. Biswas SK, Islam MS, Jia F, Cao Y, Li Y, Cao C. Flexible Biosensors for Food Pathogen Detection. Advanced Electronic Materials. 2024. DOI: https://doi.org/10.1002/aelm.202300898

35. Neubauer M, Bokelmann S, Holmes O, Foreman CM, Warnat S. Microfabricated Electrochemical Sensors as a Sentinel System to Detect Biofilms in River Systems. ECS Meeting Abstracts. 2025. DOI: https://doi.org/10.1149/ma2025-02632961mtgabs

36. Pipliya S, Kaur J, Pal A, Saha D, Patel J, Samadder S, et al.. Electrochemical biosensors for food spoilage, quality monitoring, and food safety: recent advances, sensor performance, and smart packaging integration. Frontiers in Sustainable Food Systems. 2026. DOI: https://doi.org/10.3389/fsufs.2026.1814448

37. Karakas C, Ozoglu O, Yildirim S, Sagdic O, Gurmen S, Dertli E, et al.. Two-dimensional (2D) Transition Metal Carbides/Nitrides (MXenes) and Transition Metal Borides (MBenes) as Emerging Functional Materials for Electrochemical Detection of Food Contaminants. Food Chemistry. 2026. DOI: https://doi.org/10.1016/j.foodchem.2026.148620

38. Assudani P, P. B, A AL, George G, Avthankar A, Tiwari A, et al.. Biosensing technologies for foodborne pathogen detection and healthcare: principles, emerging materials, and intelligent platforms. Mikrochimica Acta. 2026. DOI: https://doi.org/10.1007/s00604-026-07976-x

39. Gattani A, Singh S, Agrawal A, Khan MH, Singh P. Recent progress in electrochemical biosensors as point of care diagnostics in livestock health. Analytical Biochemistry. 2019. DOI: https://doi.org/10.1016/j.ab.2019.05.014

40. Choi D, An J, Lee N, Park H, Kong M. Engineered phage tail spike protein-based magnetic separation (T-MS) for rapid isolation and selective detection of viable Salmonella. Talanta. 2026. DOI: https://doi.org/10.1016/j.talanta.2026.129595

41. Jeong Y, Lee J, Choi S, Shin D, Jang S, Son S, et al.. On-site detection of airborne foodborne pathogens using a field-deployable recombinase polymerase amplification and CRISPR/Cas12a cleavage activity assay. Biosensors and Bioelectronics. 2026. DOI: https://doi.org/10.1016/j.bios.2026.118571

42. Cai H, Yu Z, Tian Z. Functional biosensing and bioimaging of extracellular vesicles: Towards integrated one-health applications . TrAC Trends in Analytical Chemistry. 2026. DOI: https://doi.org/10.1016/j.trac.2026.118855

43. Silva C, Nascimento G, Cruz P, Arancibia R, Andrade Belitardo E, Castro T, et al.. Design principles for LAMP-CRISPR molecular diagnostics. Methods. 2026. DOI: https://doi.org/10.1016/j.ymeth.2026.03.014

44. Daou M, Aldhuhoori M, Al Hajeri M, Wadi V, Hasan S, Yousef A, et al.. Advances in molecular diagnostic tools for microbial detection in wastewater: A comprehensive review. Heliyon. 2026. DOI: https://doi.org/10.1016/j.heliyon.2026.e44998

45. Wieland T, Assmann J, Bethe A, Fidelak C, Gmoser H, Jansen T, et al.. A Real-Time Thermal Sensor System for Quantifying the Inhibitory Effect of Antimicrobial Peptides on Bacterial Adhesion and Biofilm Formation. Italian National Conference on Sensors. 2021. DOI: https://doi.org/10.3390/s21082771

46. Mukendi MD, Salami OS, Mketo N. An In-Depth Review of Molecularly Imprinted Electrochemical Sensors as an Innovative Analytical Tool in Water Quality Monitoring: Architecture, Principles, Fabrication, and Applications. Micromachines. 2025. DOI: https://doi.org/10.3390/mi16030251

47. Kim D, Yoo S. Electrochemical Sensors for Antibiotic Susceptibility Testing: Strategies and Applications. Chemosensors. 2022. DOI: https://doi.org/10.3390/chemosensors10020053

48. Verma V, Kiran MG, Janbaz R, Deshmukh R. Hybrid Nanointerfaces Empower Electrochemical DNA Biosensors for Escherichia Coli Detection. Analysis & Sensing. 2025. DOI: https://doi.org/10.1002/anse.202500084

49. Dogra P, Srivastava M, Sagar P, Tripathi C, Srivastava SK. Wireless and portable smartphone assisted electrochemical platform for on-site monitoring of chloramphenicol drug. Biosensors & bioelectronics. 2025. DOI: https://doi.org/10.1016/j.bios.2025.117694

50. Heine V, Kremers T, Menzel N, Schnakenberg U, Elling L. Electrochemical Impedance Spectroscopy Biosensor Enabling Kinetic Monitoring of Fucosyltransferase Activity. ACS Sensors. 2021. DOI: https://doi.org/10.1021/acssensors.0c02206

51. Hannah A, Ward AC, Connolly P. Rapidly Detected Common Wound Pathogens via Easy-to-Use Electrochemical Sensors. Journal of Biomedical Engineering and Biosciences. 2021. DOI: https://doi.org/10.11159/jbeb.2021.002

52. Lee J, Jeong Y, Choi S, Shin D, Nam H, Yoon T, et al.. Development of a portable real-time PCR system for on-site detection of airborne bacteria. Sensors and Actuators Reports. 2026. DOI: https://doi.org/10.1016/j.snr.2026.100470

53. DrisyaM K, Rajan A, Mk D. Edible Plant Based Sensors for Real Time Health Monitoring. Asian Journal of Pharmaceutical Research and Development. 2025. DOI: https://doi.org/10.22270/ajprd.v13i6.1666

54. A S, Kavitha K, S J, J.S SK, A AAK. Portable Multi-Sensor Device for Real-Time Detection of Food borne Pathogens and Contamination. 2025 International Conference on Innovative Trends in Information Technology (ICITIIT). 2025. DOI: https://doi.org/10.1109/ICITIIT64777.2025.11040349

55. Barreda-Garcia S, Miranda-Castro R, de-los-Santos-Alvarez N, Lobo-Castanon M. Sequence-specific electrochemical detection of enzymatic amplification products of Salmonella genome on ITO electrodes improves pathogen detection to the single copy level. Sensors and Actuators B: Chemical. 2018. DOI: https://doi.org/10.1016/J.SNB.2018.04.133

56. Pola CC, Hjort RG, Garland N, Soares RRA, Johnson ZT, Claussen JC, et al.. Flexible Graphene-Based Sensors for Electrochemical Analysis of Human Saliva and Sweat. ECS Meeting Abstracts. 2024. DOI: https://doi.org/10.1149/ma2024-01502742mtgabs

57. Pereira R, Munoz-Berbel X, Sillankorva S. Microneedle-integrated biosensors for smart wound monitoring. Biosensors and Bioelectronics. 2026. DOI: https://doi.org/10.1016/j.bios.2026.118547